http://fasb.org/us-gaap/2024#RelatedPartyMemberhttp://fasb.org/us-gaap/2024#RelatedPartyMember00479166747916670001915328--12-312024Q2762500762500http://fasb.org/us-gaap/2024#RelatedPartyMemberhttp://fasb.org/us-gaap/2024#RelatedPartyMember725961514375000false0001915328us-gaap:WarrantMemberus-gaap:CommonClassAMember2024-06-300001915328isrlu:CommonClassSubjectToPossibleRedemptionMember2024-06-300001915328isrlu:CommonClassaSubjectToRedemptionMember2024-06-300001915328isrlu:CommonClassaSubjectToRedemptionMember2023-12-310001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2024-06-300001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMember2024-06-300001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2024-03-310001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2023-12-310001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMember2023-12-310001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2023-06-300001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2023-03-310001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2024-04-012024-06-300001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2023-04-012023-06-300001915328isrlu:FounderSharesMemberisrlu:SponsorMemberus-gaap:CommonClassBMember2022-01-262022-01-260001915328us-gaap:RetainedEarningsMember2024-06-300001915328us-gaap:RetainedEarningsMember2024-03-3100019153282024-03-310001915328us-gaap:RetainedEarningsMember2023-12-310001915328us-gaap:RetainedEarningsMember2023-06-300001915328us-gaap:RetainedEarningsMember2023-03-3100019153282023-03-310001915328us-gaap:RetainedEarningsMember2022-12-310001915328us-gaap:AdditionalPaidInCapitalMember2022-12-310001915328us-gaap:IPOMember2023-01-080001915328isrlu:FounderSharesMemberisrlu:SponsorMemberus-gaap:CommonClassBMember2022-01-260001915328us-gaap:CommonClassBMemberus-gaap:CommonStockMember2024-06-300001915328us-gaap:CommonClassAMemberus-gaap:CommonStockMember2024-06-300001915328us-gaap:CommonClassBMemberus-gaap:CommonStockMember2024-03-310001915328us-gaap:CommonClassAMemberus-gaap:CommonStockMember2024-03-310001915328us-gaap:CommonClassBMemberus-gaap:CommonStockMember2023-12-310001915328us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-12-310001915328us-gaap:CommonClassBMemberus-gaap:CommonStockMember2023-06-300001915328isrlu:ClassOrdinarySharesNotSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2023-06-300001915328us-gaap:CommonClassBMemberus-gaap:CommonStockMember2023-03-310001915328isrlu:ClassOrdinarySharesNotSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2023-03-310001915328us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-12-310001915328isrlu:PromissoryNoteWithRelatedPartyMember2023-01-182023-01-180001915328us-gaap:PrivatePlacementMember2023-01-012023-06-300001915328isrlu:PromissoryNoteWithRelatedPartyMemberus-gaap:RelatedPartyMember2023-01-180001915328isrlu:AdministrativeServicesAgreementMember2023-01-012023-12-310001915328isrlu:JulyPromissoryNoteMemberus-gaap:SubsequentEventMember2024-08-140001915328isrlu:WorkingCapitalLoanMemberisrlu:RelatedPartyLoanMember2024-06-300001915328isrlu:PromissoryNoteWithRelatedPartyMemberus-gaap:RelatedPartyMember2024-06-300001915328isrlu:PromissoryNoteWithRelatedPartyMemberisrlu:SponsorMember2024-06-300001915328isrlu:WorkingCapitalLoanMemberisrlu:RelatedPartyLoanMember2023-12-310001915328isrlu:PromissoryNoteWithRelatedPartyMemberus-gaap:RelatedPartyMember2023-12-310001915328isrlu:PromissoryNoteWithRelatedPartyMemberisrlu:SponsorMember2023-12-310001915328isrlu:CommonClassSubjectToPossibleRedemptionMember2023-01-192023-06-300001915328isrlu:CommonClassNotSubjectToPossibleRedemptionMember2023-01-192023-06-300001915328isrlu:CommonClassBNotSubjectToPossibleRedemptionMember2023-01-192023-06-300001915328isrlu:CommonClassBNotSubjectToPossibleRedemptionMember2023-01-012023-01-180001915328us-gaap:RetainedEarningsMember2024-04-012024-06-300001915328us-gaap:RetainedEarningsMember2024-01-012024-03-3100019153282024-01-012024-03-310001915328us-gaap:RetainedEarningsMember2023-04-012023-06-3000019153282023-01-192023-06-300001915328us-gaap:RetainedEarningsMember2023-01-012023-03-3100019153282023-01-012023-01-180001915328us-gaap:RelatedPartyMember2024-04-012024-06-300001915328us-gaap:NonrelatedPartyMember2024-04-012024-06-300001915328isrlu:AdministrativeServicesAgreementMember2024-04-012024-06-300001915328us-gaap:RelatedPartyMember2024-01-012024-06-300001915328us-gaap:NonrelatedPartyMember2024-01-012024-06-300001915328us-gaap:RelatedPartyMember2023-04-012023-06-300001915328us-gaap:NonrelatedPartyMember2023-04-012023-06-300001915328isrlu:AdministrativeServicesAgreementMember2023-04-012023-06-300001915328us-gaap:RelatedPartyMember2023-01-012023-06-300001915328us-gaap:NonrelatedPartyMember2023-01-012023-06-300001915328isrlu:AdministrativeServicesAgreementMember2023-01-012023-06-300001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMember2024-04-012024-06-300001915328isrlu:ClassOrdinarySharesNotSubjectToPossibleRedemptionMember2024-04-012024-06-300001915328isrlu:ClassBOrdinarySharesNotSubjectToPossibleRedemptionsMember2024-04-012024-06-300001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMember2024-01-012024-06-300001915328isrlu:ClassOrdinarySharesNotSubjectToPossibleRedemptionMember2024-01-012024-06-300001915328isrlu:ClassBOrdinarySharesNotSubjectToPossibleRedemptionsMember2024-01-012024-06-300001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMember2023-04-012023-06-300001915328isrlu:ClassOrdinarySharesNotSubjectToPossibleRedemptionMember2023-04-012023-06-300001915328isrlu:ClassBOrdinarySharesNotSubjectToPossibleRedemptionsMember2023-04-012023-06-300001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMember2023-01-012023-06-300001915328isrlu:ClassOrdinarySharesNotSubjectToPossibleRedemptionMember2023-01-012023-06-300001915328isrlu:ClassBOrdinarySharesNotSubjectToPossibleRedemptionsMember2023-01-012023-06-3000019153282024-01-080001915328isrlu:JulyPromissoryNoteMemberus-gaap:SubsequentEventMember2024-07-170001915328isrlu:PromissoryNoteWithRelatedPartyMemberisrlu:SponsorMember2024-01-180001915328isrlu:PromissoryNoteWithRelatedPartyMember2022-01-260001915328isrlu:FounderSharesMemberisrlu:SponsorMember2022-11-170001915328us-gaap:CommonClassBMember2022-11-170001915328isrlu:FounderSharesMemberisrlu:SponsorMember2022-08-180001915328us-gaap:CommonClassBMember2022-08-180001915328isrlu:FounderSharesMemberisrlu:SponsorMember2022-03-040001915328isrlu:CommonClassaNotSubjectToRedemptionMember2024-06-300001915328isrlu:ClassOrdinarySharesNotSubjectToPossibleRedemptionMember2024-06-300001915328isrlu:CommonClassaNotSubjectToRedemptionMember2023-12-310001915328isrlu:ClassOrdinarySharesNotSubjectToPossibleRedemptionMember2023-12-310001915328us-gaap:CommonClassAMember2024-06-300001915328us-gaap:CommonClassBMember2023-12-310001915328us-gaap:CommonClassAMember2023-12-310001915328isrlu:PublicSharesMemberus-gaap:CommonClassAMemberus-gaap:IPOMember2023-01-180001915328isrlu:PrivateSharesMemberus-gaap:CommonClassAMemberus-gaap:IPOMember2023-01-180001915328isrlu:PrivateSharesMemberus-gaap:CommonClassAMember2023-01-180001915328us-gaap:PrivatePlacementMember2024-06-300001915328isrlu:PublicWarrantsMemberus-gaap:IPOMember2023-01-180001915328us-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2024-06-300001915328us-gaap:WarrantMemberus-gaap:CommonClassAMember2023-01-180001915328isrlu:PublicWarrantsMemberus-gaap:CommonClassAMember2023-01-180001915328isrlu:PrivatePlacementWarrantsMemberus-gaap:IPOMember2023-01-1800019153282023-06-3000019153282022-12-310001915328isrlu:FounderSharesMemberisrlu:SponsorMemberus-gaap:CommonClassBMember2022-03-040001915328us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001915328us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001915328isrlu:PublicSharesMemberus-gaap:IPOMember2023-01-182023-01-180001915328us-gaap:IPOMember2024-01-012024-06-300001915328us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMember2024-01-082024-01-080001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2024-01-012024-03-310001915328isrlu:ClassOrdinarySharesSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2023-01-012023-03-310001915328isrlu:CommonClassSubjectToPossibleRedemptionMember2024-04-012024-06-300001915328isrlu:CommonClassNotSubjectToPossibleRedemptionMember2024-04-012024-06-300001915328isrlu:CommonClassBNotSubjectToPossibleRedemptionMember2024-04-012024-06-300001915328isrlu:CommonClassSubjectToPossibleRedemptionMember2024-01-012024-06-300001915328isrlu:CommonClassNotSubjectToPossibleRedemptionMember2024-01-012024-06-300001915328isrlu:CommonClassBNotSubjectToPossibleRedemptionMember2024-01-012024-06-300001915328isrlu:CommonClassSubjectToPossibleRedemptionMember2023-04-012023-06-300001915328isrlu:CommonClassNotSubjectToPossibleRedemptionMember2023-04-012023-06-300001915328isrlu:CommonClassBNotSubjectToPossibleRedemptionMember2023-04-012023-06-300001915328isrlu:CommonClassSubjectToPossibleRedemptionMember2023-01-012023-06-300001915328isrlu:CommonClassNotSubjectToPossibleRedemptionMember2023-01-012023-06-300001915328isrlu:CommonClassBNotSubjectToPossibleRedemptionMember2023-01-012023-06-300001915328isrlu:FounderSharesMemberisrlu:SponsorMember2023-05-072023-05-070001915328isrlu:FounderSharesMemberus-gaap:CommonClassBMember2022-03-042022-03-040001915328isrlu:FounderSharesMemberisrlu:SponsorMember2022-03-042022-03-040001915328isrlu:SponsorMemberus-gaap:CommonClassBMember2022-11-172022-11-170001915328isrlu:SponsorMemberus-gaap:CommonClassBMember2022-08-182022-08-180001915328isrlu:FounderSharesMemberisrlu:SponsorMember2022-11-172022-11-170001915328isrlu:FounderSharesMemberisrlu:SponsorMember2022-08-182022-08-180001915328isrlu:PublicWarrantsMember2024-06-300001915328isrlu:ClassOrdinarySharesNotSubjectToPossibleRedemptionMemberus-gaap:CommonStockMember2023-01-012023-03-310001915328isrlu:AdministrativeServicesAgreementMember2024-01-012024-06-300001915328isrlu:PromissoryNoteWithRelatedPartyMemberisrlu:SponsorMember2024-06-142024-06-140001915328isrlu:PromissoryNoteWithRelatedPartyMemberisrlu:SponsorMember2024-05-172024-05-170001915328isrlu:PromissoryNoteWithRelatedPartyMemberisrlu:SponsorMember2024-04-152024-04-150001915328isrlu:PromissoryNoteWithRelatedPartyMemberisrlu:SponsorMember2024-03-112024-03-110001915328isrlu:PromissoryNoteWithRelatedPartyMemberisrlu:SponsorMember2024-02-152024-02-150001915328isrlu:PromissoryNoteWithRelatedPartyMemberisrlu:SponsorMember2024-01-162024-01-160001915328isrlu:PublicSharesMemberus-gaap:IPOMember2023-01-180001915328isrlu:PublicWarrantsMember2024-01-012024-06-300001915328us-gaap:IPOMember2024-06-300001915328isrlu:PrivatePlacementWarrantsMemberus-gaap:IPOMember2023-01-182023-01-180001915328us-gaap:PrivatePlacementMember2024-01-012024-06-300001915328isrlu:PrivateSharesMemberus-gaap:CommonClassAMemberus-gaap:IPOMember2023-01-182023-01-180001915328isrlu:PublicWarrantsMemberus-gaap:IPOMember2023-01-182023-01-180001915328isrlu:PromissoryNoteWithRelatedPartyMemberisrlu:SponsorMember2024-01-182024-01-180001915328us-gaap:MoneyMarketFundsMember2023-01-182023-01-180001915328us-gaap:IPOMember2023-01-180001915328srt:MaximumMember2024-01-012024-06-300001915328us-gaap:WarrantMember2024-01-012024-06-300001915328isrlu:PromissoryNoteWithRelatedPartyMember2023-01-180001915328isrlu:WorkingCapitalLoanMemberisrlu:RelatedPartyLoanMember2024-01-012024-06-300001915328us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100019153282023-01-012023-03-310001915328isrlu:CommonClassSubjectToPossibleRedemptionMember2023-01-012023-12-310001915328us-gaap:OverAllotmentOptionMember2024-01-012024-06-3000019153282023-04-012023-06-300001915328us-gaap:OverAllotmentOptionMember2024-06-3000019153282023-01-012023-06-3000019153282024-06-3000019153282023-12-310001915328us-gaap:CommonClassBMember2024-01-012024-06-300001915328us-gaap:IPOMember2023-01-182023-01-1800019153282021-08-242021-08-240001915328us-gaap:CommonClassBMember2024-06-300001915328us-gaap:WarrantMemberus-gaap:CommonClassAMember2024-01-012024-06-300001915328isrlu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Memberisrlu:PrivatePlacementWarrantsMember2024-01-012024-06-300001915328isrlu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Memberisrlu:PublicWarrantsMember2024-01-012024-06-300001915328isrlu:PublicSharesMemberus-gaap:IPOMember2024-01-082024-01-0800019153282024-01-082024-01-080001915328isrlu:SponsorMemberus-gaap:CommonClassBMember2024-01-012024-06-300001915328us-gaap:SubsequentEventMember2024-07-1700019153282024-04-012024-06-300001915328us-gaap:CommonClassAMember2024-01-012024-06-300001915328isrlu:UnitsofeachconsistingofoneclassaordinaryshareandoneredeemablewarrantMember2024-01-012024-06-300001915328isrlu:RedeemableWarrantExercisableForClassCommonStockMember2024-01-012024-06-300001915328us-gaap:CommonClassBMember2024-08-140001915328us-gaap:CommonClassAMember2024-08-1400019153282024-01-012024-06-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesisrlu:itemisrlu:Votexbrli:pureisrlu:Misrlu:D

FORM 10-Q

(MARK ONE)

   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended June 30, 2024

   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-41593

ISRAEL ACQUISITIONS CORP

(Exact Name of Registrant as Specified in Its Charter)

Cayman Islands

    

87-3587394

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

12600 Hill Country Blvd, Building R, Suite 275

Bee Cave, Texas 78738

(Address of principal executive offices)

(800) 508-1531

(Issuer’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Units, each consisting of one Class A ordinary share and one redeemable warrant

ISRLU

The Nasdaq Stock Market LLC

Class A ordinary shares, par value $0.0001 per share

ISRL

The Nasdaq Stock Market LLC

Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share

ISRLW

The Nasdaq Stock Market LLC

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of August 14 2024, there were 8,022,115 Class A ordinary shares, par value $0.0001 per share issued and outstanding and 4,791,667 Class B ordinary shares, par value $0.0001 per share issued and outstanding.

TABLE OF CONTENTS

Page

PART I - FINANCIAL INFORMATION

2

Item 1. Interim Financial Statements (unaudited).

2

Condensed Balance Sheets as of June 30, 2024 and December 31, 2023

2

Condensed Statements of Operations for the three and six months ended June 30, 2024 and 2023

3

Condensed Statements of Changes in Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit for the three and six months ended June 30, 2024 and 2023

4

Condensed Statements of Cash Flows for the six months ended June 30, 2024 and 2023

5

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

22

Item 3. Quantitative and Qualitative Disclosures About Market Risk

25

Item 4. Controls and Procedures

25

PART II - OTHER INFORMATION

27

Item 1. Legal Proceedings

27

Item 1.A. Risk Factors

27

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

27

Item 3. Defaults Upon Senior Securities

27

Item 4. Mine Safety Disclosures

27

Item 5. Other Information

27

Item 6. Exhibits

28

PART III - SIGNATURES

29

1

PART I - FINANCIAL INFORMATION

Item 1. Interim Financial Statements.

ISRAEL ACQUISITIONS CORP

CONDENSED BALANCE SHEETS

(UNAUDITED)

June 30,

December 31, 

    

2024

    

2023

ASSETS

Current assets:

 

  

 

  

Cash and cash equivalents

$

66,926

$

671,628

Prepaid expenses

 

70,056

 

145,114

Cash and Marketable Securities held in Trust Account

 

80,313,771

 

153,702,006

Total Current Assets

 

80,450,753

 

154,518,748

Total Assets

$

80,450,753

$

154,518,748

LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT

Current liabilities:

 

  

 

  

Accrued expenses

$

314,186

$

55,000

Accounts payable

 

126,498

 

91,139

Due to related party

60,000

116,129

Promissory note – related party

300,000

Deferred underwriting commissions

5,406,250

5,406,250

Total Current Liabilities

6,206,934

5,668,518

Total Liabilities

 

6,206,934

 

5,668,518

Commitments and Contingencies (Note 5)

 

  

 

  

Class A ordinary shares subject to possible redemption, $0.0001 par value; 7,259,615 and 14,375,000 shares issued and outstanding at redemption value at June 30, 2024 and December 31, 2023, respectively

80,313,771

153,702,006

Shareholders’ Deficit

 

 

Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding

 

 

Class A ordinary shares, $0.0001 par value, 200,000,000 shares authorized; 762,500 shares issued and outstanding (excluding 7,259,615 and 14,375,000 shares subject to possible redemption) at June 30, 2024 and December 31, 2023, respectively

 

76

 

76

Class B ordinary shares, $0.0001 par value, 20,000,000 shares authorized; 4,791,667 shares issued and outstanding at June 30, 2024 and December 31, 2023

 

479

 

479

Additional paid-in capital

 

 

Accumulated deficit

 

(6,070,507)

 

(4,852,331)

Total Shareholders’ Deficit

 

(6,069,952)

 

(4,851,776)

TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT

$

80,450,753

$

154,518,748

The accompanying notes are an integral part of these unaudited condensed financial statements.

2

ISRAEL ACQUISITIONS CORP

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

For the Three

For the Three

For the Six

For the Six

Months Ended

Months Ended

Months Ended

Months Ended

June 30, 

June 30, 

June 30, 

June 30, 

    

2024

    

2023

    

2024

    

2023

Marketing and advertising expense

$

$

$

$

3,732

Administrative expense

6,004

99,963

13,033

104,719

Administrative expense – related party

30,000

30,000

60,000

56,129

Legal and accounting expense

151,845

115,887

530,425

244,071

Dues and subscriptions expense

37,240

3,198

71,775

5,848

Listing fee expense

4,425

5,550

121,889

10,763

Insurance expense

64,167

64,167

128,334

120,054

Loss from operations

(293,681)

(318,765)

(925,456)

(545,316)

Other income:

Unrealized gain on marketable securities held in Trust Account

1,743,572

3,102,884

Dividend income on marketable securities held in Trust Account

1,031,091

7

2,232,923

10

Dividend income

1,480

10,991

7,278

22,073

Interest income

1

1

2

120

Other income, net

1,032,572

1,754,571

2,240,203

3,125,087

Net income

$

738,891

$

1,435,806

$

1,314,747

$

2,579,771

Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption

7,259,615

14,375,000

7,572,379

13,024,862

Basic and diluted net income per share, Class A ordinary shares subject to possible redemption

$

0.13

$

0.11

$

0.24

$

0.46

Basic and diluted weighted average shares outstanding, non-redeemable Class A ordinary shares

762,500

762,500

762,500

690,884

Basic and diluted net loss per share, non-redeemable Class A ordinary shares

$

(0.03)

$

(0.02)

$

(0.10)

$

(0.69)

Basic and diluted weighted average shares outstanding, non-redeemable Class B ordinary shares

4,791,667

4,791,667

4,791,667

4,791,667

Basic and diluted net loss per share, non-redeemable Class B ordinary shares

$

(0.03)

$

(0.02)

$

(0.10)

$

(0.62)

The accompanying notes are an integral part of these unaudited condensed financial statements.

3

ISRAEL ACQUISITIONS CORP

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT

Class A

    

Ordinary Shares Subject to Possible

Class A

Class B

Additional

Total

Redemption

Ordinary Shares

Ordinary Shares

Paid-in

Accumulated

Shareholders’

    

Shares

    

Amount

  

  

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Deficit

    

Deficit

Balance – December 31, 2023

 

14,375,000

$

153,702,006

 

762,500

$

76

 

4,791,667

$

479

$

$

(4,852,331)

$

(4,851,776)

Remeasurement of Class A ordinary shares to redemption value

 

 

1,351,832

 

 

 

 

 

 

(1,351,832)

 

(1,351,832)

Redemption of Class A ordinary shares

(7,115,385)

(75,921,158)

Net income

575,856

575,856

Balance - March 31, 2024

7,259,615

79,132,680

762,500

$

76

4,791,667

$

479

$

$

(5,628,307)

$

(5,627,752)

Remeasurement of Class A ordinary shares to redemption value

1,181,091

(1,181,091)

(1,181,091)

Net income

738,891

738,891

Balance – June 30, 2024

 

7,259,615

80,313,771

762,500

$

76

4,791,667

$

479

$

$

(6,070,507)

$

(6,069,952)

Class A

    

Ordinary Shares Subject to Possible

Class A

Class B

Additional

Total

Redemption

Ordinary Shares

Ordinary Shares

Paid-in

Accumulated

Shareholders’

    

Shares

    

Amount

  

  

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Deficit

    

Deficit

Balance – December 31, 2022

 

$

 

$

 

4,791,667

$

479

$

24,521

$

(77,000)

$

(52,000)

Issuance of Class A ordinary shares in initial public offering

14,375,000

134,753,406

354,359

354,359

Sale of private placement units

 

 

 

762,500

 

76

 

 

 

7,624,924

 

 

7,625,000

Remeasurement of Class A ordinary shares to redemption value

13,230,909

(8,003,804)

(5,227,105)

(13,230,909)

Net income

1,143,965

1,143,965

Balance - March 31, 2023

14,375,000

147,984,315

762,500

$

76

4,791,667

$

479

$

$

(4,160,140)

$

(4,159,585)

Transfer of Founder Shares

95,990

95,990

Remeasurement of Class A ordinary shares to redemption value

1,743,579

(95,990)

(1,647,589)

(1,743,579)

Net income

1,435,806

1,435,806

Balance – June 30, 2023

14,375,000

149,727,894

762,500

$

76

4,791,667

$

479

$

$

(4,371,923)

$

(4,371,368)

The accompanying notes are an integral part of these unaudited condensed financial statements.

4

ISRAEL ACQUISITIONS CORP

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

Six Months

Six Months

Ended

Ended

June 30, 

June 30, 

    

2024

    

2023

Cash Flows from Operating Activities:

 

  

 

  

Net income

$

1,314,747

$

2,579,771

Adjustments to reconcile net income (loss) to net cash used in operating activities:

 

 

Unrealized gain on marketable securities held in Trust Account

 

 

(3,102,884)

Excess fair value of transfer of Founder Shares

95,990

Changes in operating assets and liabilities:

 

 

Prepaid expenses

 

75,058

(264,946)

Due to related party

(56,129)

56,129

Accounts payable

35,359

48,455

Accrued expenses

259,186

(45,010)

Net cash provided by (used in) operating activities

 

1,628,221

(632,495)

Cash Flows from Investing Activities:

Purchase and reinvestment of marketable securities held in Trust Account

(2,532,923)

(146,625,010)

Proceeds from redemption of marketable securities held in Trust Account

75,921,158

Net cash provided by (used in) investing activities

73,388,235

(146,625,010)

Cash Flows from Financing Activities:

 

 

  

Proceeds from issuance of ordinary shares

 

 

141,250,000

Proceeds from sale of private placement units

 

 

7,625,000

Payment of promissory note – related party

(237,234)

Payment of offering costs

(487,401)

Proceeds from promissory note – related party

300,000

Redemptions of Class A ordinary shares subject to redemption

(75,921,158)

Net cash (used in) provided by financing activities

 

(75,621,158)

148,150,365

Net Change in Cash and Cash Equivalents

 

(604,702)

892,860

Cash and Cash Equivalents - Beginning

 

671,628

8,305

Cash and Cash Equivalents - Ending

$

66,926

$

901,165

Non-Cash Investing and Financing Activities:

 

 

Remeasurement of Class A ordinary shares subject to possible redemption

$

2,532,923

$

14,974,488

Deferred underwriter fee payable

$

$

5,406,250

The accompanying notes are an integral part of these unaudited condensed financial statements.

5

ISRAEL ACQUISITIONS CORP

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 1 — Description of Organization, Business Operations and Liquidity and Capital Resources

Israel Acquisitions Corp (the “Company”) was incorporated as a blank check company in the Cayman Islands on August 24, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and is subject to all of the risks associated with emerging growth companies.

As of June 30, 2024, the Company had not commenced any operations. All activity for the period from August 24, 2021 (inception) through June 30, 2024 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), and, since the completion of the Initial Public Offering, a search for a target to consummate a Business Combination. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of gains on marketable securities held in the Trust Account, as well as interest and dividend income on cash and cash equivalents from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering was declared effective on January 12, 2023 (the “Registration Statement”). On January 18, 2023, the Company consummated its Initial Public Offering of 14,375,000 units (each a “Public Unit” and the “Public Units”) at $10.00 per Public Unit (including the issuance of 1,875,000 Public Units as a result of the underwriters’ exercise of heir over-allotment option in full), generating gross proceeds of $143,750,000, which is discussed in Note 3. Each Public Unit is comprised of one Class A ordinary share, par value $0.001 per share (each, a “Public Share” and the “Public Shares”) and one redeemable warrant evidencing the right to purchase one Class A ordinary share at a purchase price of $11.50 per Class A ordinary share (each a “Public Warrant” and the “Public Warrants”). Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 762,500 private placement units (each, a “Private Unit” and the “Private Units”) to Israel Acquisitions Sponsor LLC (the “Sponsor”), BTIG, LLC, Exos Capital LLC, and JonesTrading Institutional Services LLC, in a private placement at a purchase price of $10.00 per Private Unit, for an aggregate of $7,625,000. Each Private Unit is comprised of one Class A ordinary share, par value $0.001 per share (each, a “Private Share” and the “Private Shares”) and one redeemable warrant evidencing the right to purchase one Class A ordinary share, par value $0.0001 per share, at a purchase price of $11.50 (each, a “Private Warrant” and the “Private Warrants”).

Following the closing of the Initial Public Offering on January 18, 2023, $146,625,000 ($10.20 per Public Unit) from the net proceeds of the sale of the Public Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (“Trust Account”), located in the United States which will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of the Company’s initial business combination; (ii) the redemption of any Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association, adopted on November 17, 2022 (the “Amended and Restated Memorandum and Articles of Association”), and (iii) the redemption of the Company’s Public Shares if the Company is unable to complete an initial business combination by January 18, 2024 (or up to July 18, 2024, if the Company extends the time to complete an initial business combination) (the “Combination Period”).

On January 8, 2024, by special resolution and at an extraordinary general meeting of shareholders, the Company (i) entered into an amendment (the “Trust Agreement Amendment”) to the Invest Management Trust Agreement dated as of January 12, 2023 (the “Trust Agreement”), with Equiniti Trust Company, LLC (f/k/a American Stock Transfer & Trust Company) (the “Trustee”) and (ii) amended the Company’s Second Amended and Restated Memorandum and Articles of Association, in its entirety, by adopting the Company’s Third Amended and Restated Memorandum and Articles of Association, pursuant to which the Company may extend the date by which the Company must consummate an initial business combination (the “Termination Date”) from 12 months from the closing of the Initial Public Offering (January 18, 2024) up to twelve (12) times (each, an “Extension”) to January 18, 2025, with each Extension comprised of one month. Pursuant to the Trust Agreement Amendment, the Company can extend the Termination Date by providing five days’ advance notice to the Trustee prior to the applicable Extension and depositing into the Trust Account the lesser of (i) $50,000 or (ii) $0.02 per Public Share, multiplied by the number of Public Shares that remain outstanding by the end of the then-current extended period, by the date of such Extension.

6

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating an initial business combination. There is no assurance that the Company will be able to complete an initial business combination successfully. The Company must complete an initial business combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial business combination. The Company will only complete an initial business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

The Company will provide its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of an initial business combination either (i) in connection with a shareholder meeting called to approve the initial business combination or (ii) by means of a tender offer. Except as required by law or the rules of Nasdaq, the decision as to whether the Company will seek shareholder approval of an initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account. There will be no redemption rights upon the completion of an initial business combination with respect to the Company’s warrants.

The Company will proceed with an initial business combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of an initial business combination and, if the Company seeks shareholder approval, a majority of the ordinary shares voted are voted in favor of the initial business combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing an initial business combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with an initial business combination, the Sponsor and our executive officers and directors have agreed (a) to vote their Founder Shares (as defined in this Note 1), Private Shares, and any Public Shares purchased during or after the Initial Public Offering in favor of approving an initial business combination and (b) not to convert any Founder Shares, Private Shares, or any Public Shares held by them in connection with a shareholder vote to approve an initial business combination or sell any such shares to the Company in a tender offer in connection with an initial business combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.

The Sponsor and our executive officers and directors have agreed (a) to waive their respective redemption rights with respect to any Founder Shares, Private Shares, or Public Shares held by them in connection with the completion of an initial business combination, (b) to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Shares if the Company fails to consummate an initial business combination, and (c) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association that would affect a public shareholders’ ability to convert or sell their Public Shares to the Company in connection with an initial business combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete an initial business combination, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

If the Company is unable to complete an initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors (the “Board”), dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s Public Warrants or Private Warrants, which will expire worthless if the Company fails to complete an initial business combination within the Combination Period.

7

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.20 per Public Share, except as to any claims by a third party that executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Business Combination Agreement

On January 2, 2024, the Company entered into a business combination agreement with Pomvom Ltd., a company organized under the laws of Israel (“Pomvom,” and such agreement, the “Business Combination Agreement”), pursuant to which, among other things and subject to the terms and conditions contained therein (i) Pomvom will cause a company organized under the laws of the State of Israel and wholly owned by a trustee (the “NewPubCo”) to be formed, (ii) Pomvom will cause a Cayman Islands exempted company and wholly owned, direct subsidiary of NewPubco (“Merger Sub”) to be formed, (iii) Pomvom will cause NewPubCo and Merger Sub to become a party to the Business Combination Agreement by delivering a joinder to the Business Combination Agreement, (iv) Pomvom will effect the Share Split (as defined therein), (v) NewPubco, the shareholders of Pomvom and the holders of equity awards of Pomvom will effect the Equity Exchange (as defined therein), and (vi) Merger Sub will merge with and into the Company, with the Company surviving the merger as a direct wholly owned subsidiary of NewPubCo (the “Merger”).

On April 22, 2024, we entered into an amendment with Pomvom (the “Amendment”) to the Business Combination Agreement. Pursuant to the Amendment, the we agreed with Pomvom to (i) extend the date by which all members of the board of directors of the post-combination company shall be agreed determined from April 30, 2024, to June 30, 2024, (ii) extend the date by which an independent compensation consultant shall present a benchmark analysis of the compensation packages for officers and directors of public market companies that are comparable to Pomvom and recommendations for officer and director compensation packages to the Pomvom’s compensation committee and board of directors in connection with their review and approval of such packages from April 30, 2024, to June 30, 2024, and (iii) extend the Minimum Equity Financing Proceeds Termination Date (as defined in the Business Combination Agreement) from June 30, 2024, to August 31, 2024.

Liquidity Capital Resources and Going Concern

As of June 30, 2024, the Company had $66,926 in its operating bank account and a working capital deficit of $663,702 (excluding cash and marketable securities held in the Trust Account and the deferred underwriter fee payable) compared to $671,628 in its operating bank account and working capital of $554,474 (excluding cash and marketable securities held in the Trust Account and the deferred underwriter fee payable) as of December 31, 2023.

The Company’s liquidity needs through June 30, 2024 had been satisfied through a payment from the Sponsor of $25,000 for Class B ordinary shares, par value $0.0001 per share (the “Class B ordinary shares” or the “Founder Shares”), the Initial Public Offering and the issuance of the Private Units (see Note 3 and Note 4). Additionally, the Company drew on the Promissory Note (as defined below) to pay certain offering costs (see Note 4).

8

The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company lacks the financial resources it needs to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. Although no formal agreement exists, the Sponsor is committed to extend Working Capital Loans as needed (defined in Note 4 below). Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that (i) new financing will be available to it on commercially acceptable terms, if at all, or (ii) that its plans to consummate an initial business combination will be successful. In addition, management is currently evaluating the impact of the invasion of Ukraine by Russia, the increased rate of inflation in the United States and other events (such as terrorist attacks, natural disasters or a significant outbreak of other infectious diseases) on the industry and its effect on the Company’s financial position, results of its operations and/or search for a target company.

We may need to obtain additional financing to complete our initial business combination, either because the transaction requires more cash than is available from the proceeds held in our Trust Account, or because we become obligated to redeem a significant number of our public shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such initial business combination. If we have not consummated our initial business combination within the Combination Period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account.

These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern one year from the date the financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Risks and Uncertainties

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and/or search for a target company is also not determinable as of the date of these financial statements.

In October 2023, Hamas conducted several terrorist attacks in Israel resulting in ongoing war across the country, forcing the closure of many businesses in Israel for several days. In addition, there continue to be hostilities between Israel and Hezbollah in Lebanon and Hamas in the Gaza Strip, both of which resulted in rockets being fired into Israel, causing casualties and disruption of economic activities. In early 2023, there were a number of changes proposed to the political system in Israel by the current government which, if implemented as planned, could lead to large-scale protests and additional uncertainty, negatively impacting the operating environment in Israel. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and/or search for a target company is also not determinable as of the date of these financial statements.

The specific impact of these ongoing events is not readily determinable as of the date of these financial statements and these financial statements do not include any adjustments that may result from the outcomes of these uncertainties.

Note 2 - Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, the financial statements do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

9

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2023 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The interim results for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future interim periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies.

The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statement in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of June 30, 2024 and December 31, 2023, the Company had $66,926 and $671,628 in cash and cash equivalents, respectively.

Cash and Marketable Securities held in Trust Account

Following the closing of the Initial Public Offering on January 18, 2023, an amount of $146,625,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units were placed in the Trust Account and may be invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Trust Account is intended as a holding place for funds pending the earliest to occur of: (i) the completion of the initial Business Combination; (ii) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination within 12 months from the closing of the Initial Public Offering or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within 12 months from the closing of the Initial Public Offering, the return of the funds held in the Trust Account to the public shareholders as part of redemption of the public shares.

10

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2024 and December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2024, 7,259,615 Class A ordinary shares subject to possible redemption are presented as temporary equity, at redemption value, as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit.

The Class A ordinary shares subject to possible redemption is reflected on the balance sheet at June 30, 2024 as follows:

Gross proceeds from Initial Public Offering

    

$

143,750,000

Less:

 

Proceeds allocated to public warrants

 

(354,359)

Offering costs allocated to Class A ordinary shares subject to possible redemption

 

(8,642,235)

Plus:

 

Accretion of Class A ordinary shares subject to possible redemption

 

18,948,600

Class A ordinary shares subject to possible redemption at December 31, 2023

153,702,006

Redemption of Class A ordinary shares

(75,921,158)

Re-measurement of Class A ordinary shares subject to possible redemption

2,532,923

Class A ordinary shares subject to possible redemption at June 30, 2024

$

80,313,771

Offering Costs associated with the Initial Public Offering

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of Offering”. Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. The Company incurred offering costs from the Initial Public Offering of $8,642,235, consisting of $2,500,000 of underwriting fee, $5,406,250 of deferred underwriting fee, $735,985 of actual offering costs. These amounts were recorded to additional paid-in capital as a reduction to the net proceeds from the offering.

Fair Value Measurements

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurements and Disclosures” (“ASC 820”), defines fair value as the amount that would be received to sell an asset or paid to transfer a liability, in an orderly transaction between market participants. Fair value measurements are classified on a three-tier hierarchy as follows:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

11

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. ln those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

The fair value of the Company’s assets and liabilities that qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Financial Instruments

The fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Derivative Financial Instruments

The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period. There were no derivative financial instruments accounted for as liabilities as of June 30, 2024 and December 31, 2023.

Warrants

The Company accounts for the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in FASB ASC Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). Pursuant to the Company’s evaluation, the Company concluded that the public and private do not meet the criteria to be accounted for as liability under ASC 480. The Company further evaluated the public and private warrants and rights under “ASC 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity” (“ASC 815-40”) and concluded that the public warrants, private placement warrants are indexed to the Company’s own stock and meet the criteria to be classified in shareholders’ equity.

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” (“ASC 740”) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2024 and December 31, 2023. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company is not currently aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to tax examinations by major taxing authorities since inception. There is currently no taxation imposed by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

12

There is currently no taxation imposed by the government of the Cayman Islands. The Company has no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. Consequently, income taxes are not reflected in the Company’s financial statement.

Net Income (Loss) Per Ordinary Share

The statement of operations includes a presentation of income (loss) per Class A redeemable ordinary share and income (loss) per non-redeemable ordinary share following the two-class method of income per ordinary share. In order to determine the net income (loss) attributable to both the Class A redeemable ordinary shares and non-redeemable ordinary shares, the Company first considered the total net income (loss) allocable to both sets of shares. This is calculated using the total net income (loss) less any dividends paid. For purposes of calculating net income (loss) per share, any remeasurement of the Class A ordinary shares subject to possible redemption was treated as dividends paid to the public shareholders.

Net income (loss) per ordinary share is computed by dividing net income (loss) by class by the weighted average number of ordinary shares outstanding during the period. The Company has not considered the effect of the 14,375,000 Public Warrants in the calculation of diluted net income (loss) per share, since the exercise of such warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the three months ended June 30, 2024 (in dollars, except share amounts):

    

Three Months Ended

June 30, 2024

Net income

$

738,891

Accretion of temporary equity to redemption value

 

(1,181,091)

Net loss including accretion of temporary equity to redemption value

$

(442,200)

Three Months Ended

June 30, 2024

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

418,616

$

43,969

$

276,306

Less: Accretion allocation based on ownership percentage

$

(669,144)

$

(70,282)

(441,665)

Allocation of accretion of temporary equity to redeemable shares

1,181,091

Total net income (loss) by class

$

930,563

$

(26,313)

(165,359)

Denominator:

Weighted average shares outstanding

7,259,615

762,500

4,791,667

Basic and diluted net income (loss) per share

$

0.13

$

(0.03)

(0.03)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the six months ended June 30, 2024 (in dollars, except share amounts):

    

Six Months Ended

June, 2024

Net income

$

1,314,747

Accretion of temporary equity to redemption value

 

(2,532,923)

Net loss including accretion of temporary equity to redemption value

$

(1,218,176)

13

Six Months Ended

June 30, 2024

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

744,866

$

78,236

$

491,645

Less: Accretion allocation based on ownership percentage

$

(1,435,021)

$

(150,725)

 

(947,177)

Allocation of accretion of temporary equity to redeemable shares

 

2,532,923

 

 

Total net income (loss) by class

$

1,842,768

$

(72,489)

 

(455,532)

Denominator:

 

  

 

  

 

  

Weighted average shares outstanding

 

7,572,379

 

762,500

 

4,791,667

Basic and diluted net income (loss) per share

$

0.24

$

(0.10)

 

(0.10)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the three months ended June 30, 2023 (in dollars, except share amounts):

    

Three Months Ended

June 30, 2023

Net income

$

1,435,806

Accretion of temporary equity to redemption value

 

(1,743,579)

Net loss including accretion of temporary equity to redemption value

$

(307,773)

Three Months Ended

June 30, 2023

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

1,035,653

$

54,935

$

345,218

Less: Accretion allocation based on ownership percentage

$

(1,257,652)

$

(66,710)

 

(419,217)

Allocation of accretion of temporary equity to redeemable shares

 

1,743,579

 

 

Total net income (loss) by class

$

1,521,580

$

(11,775)

 

(73,999)

Denominator:

 

  

 

  

 

  

Weighted average shares outstanding

 

1,437,000

 

762,500

 

4,791,667

Basic and diluted net income per share

$

0.11

$

(0.02)

 

(0.02)

14

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the six months ended June 30, 2023 (in dollars, except share amounts):

    

Six Months Ended

June 30, 2023

Net loss from beginning on the year to date of initial public offering

$

(6,646)

Net income from date of initial public offering to period end

 

2,586,417

Total income for the three months ended June 30, 2023

 

2,579,771

Accretion of temporary equity to redemption value

 

(14,974,488)

Net loss including accretion of temporary equity to redemption value

$

(12,394,717)

    

Six Months Ended

June 30, 2023

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

  

 

  

Numerator:

 

  

  

 

  

Allocation of net loss from inception to date of initial public offering

$

$

$

(6,646)

Allocation of net income from date of initial public offering to period end

1,865,594

98,958

621,865

Total income allocated by class

1,865,594

98,958

615,219

Less: Accretion allocation based on ownership percentage

$

(10,801,168)

$

(572,931)

(3,600,389)

Allocation of accretion of temporary equity to redeemable shares

14,974,488

Total net income (loss) by class

$

6,038,914

$

(473,973)

(2,985,170)

Denominator:

Weighted average shares outstanding

13,024,862

690,884

4,791,667

Basic and diluted net income per share

$

0.46

$

(0.69)

(0.62)

Recent Accounting Pronouncements

In December 2023, the FASB issued Accounting Standards Update 2023-09, “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which provides for additional disclosures primarily related to the income tax rate reconciliations and income taxes paid. ASU 2023-09 requires entities to annually disclose the income tax rate reconciliation using both amounts and percentages, considering several categories of reconciling items, including state and local income taxes, foreign tax effects, tax credits and nontaxable or nondeductible items, among others. Disclosure of the reconciling items is subject to a quantitative threshold and disaggregation by nature and jurisdiction. ASU 2023-09 also requires entities to disclose net income taxes paid or received to federal, state and foreign jurisdictions, as well as by individual jurisdiction, subject to a five percent quantitative threshold. ASU 2023-09 may be adopted on a prospective or retrospective basis and is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2023-09 would have on its financial position, results of operations or cash flows.

The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying financial statements.

15

Note 3 - Initial Public Offering

On January 18, 2023 the Company sold 14,375,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A ordinary share and one warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $11.50 per share (see Note 6).

An aggregate of $10.20 per Unit sold in the Initial Public Offering was deposited in the Trust Account and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. As of June 30, 2024, $80,313,771 was held in the Trust Account. In addition, $66,926 of operating cash is not held in the Trust Account and is available for working capital purposes.

Note 4 - Related Party Transactions

Founder Shares

On January 26, 2022, the Sponsor purchased 5,750,000 shares (the “Founder Shares”) of the Company’s Class B ordinary shares, par value $0.0001 (“Class B ordinary shares”) for an aggregate price of $25,000.

On March 4, 2022, the Company effected a share capitalization with respect to our Class B ordinary shares of 1,150,000, resulting in our initial shareholders holding 6,900,000 shares. On August 18, 2022, the Sponsor surrendered for no consideration 1,150,000 shares, resulting in a decrease in the total number of Class B shares outstanding to 5,750,000. On November 17, 2022 the Sponsor surrendered for no consideration 958,333 shares, resulting in a decrease in the total number of Class B shares outstanding to 4,791,667. All share and per-share amounts have been retroactively restated.

On May 7, 2023, the Sponsor transferred 95,500 of its Founder Shares to our special advisor for consulting services. The consulting services offered were considered a benefit that the Company realized as a result of the Sponsors transaction with the special advisor. The fair value of the consulting services was determined to be a financing expense in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 718.

The Founder Shares will automatically convert into Class A ordinary shares at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions, as described in Note 6. Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment, at any time.

Private Placement

The Sponsor, BTIG, LLC, Exos Capital LLC, and JonesTrading Institutional Services LLC purchased an aggregate of 762,500 Private Units at a price of $10.00 per Private Unit for an aggregate purchase price of $7,625,000 in a private placement that occurred simultaneously with the closing of the Initial Public Offering, the proceeds of which were recorded in additional paid in capital. Each Private Unit consists of one share of Class A ordinary share (“Private Share”) and one warrant (“Private Warrant”). Each Private Warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $11.50 per full share, subject to adjustment. The proceeds from the Private Units were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

16

Related Party Loans

In addition, to finance transaction costs in connection with an initial business combination, the initial shareholders, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes an initial business combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that an initial business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of an initial business combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into private placement-equivalent units of the post initial business combination entity at a price of $10.00 per private placement-equivalent unit. These units would be identical to the Private Units. As of June 30, 2024 and December 31, 2023, the Company had no outstanding Working Capital Loans.

Promissory Note – Related Party

On January 26, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. As of January 18, 2023, the Company had borrowed $237,234 under the Promissory Note. On January 18, 2023 the Company paid $245,540 to the Sponsor, resulting in an overpayment of $8,306 that was recorded as a related party receivable, which was subsequently refunded to the Company prior to December 31, 2023. The Promissory Note was non-interest bearing. As of June 30, 2024 and December 31, 2023, the outstanding balance under the Promissory Note was $0.

On January 18, 2024, the Company issued a promissory note in the amount of $600,000 to pay for up to twelve additional one-month extension payments (the “Extension Note”). On each of January 16, 2024, February 15, 2024, March 11, 2024, April 15, 2024, May 17, 2024, and June 14, 2024, the Company drew $50,000, $300,000 in the aggregate, against the Extension Note to pay for each additional one-month extension. The Extension Note bears no interest and is repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company’s initial business combination, or (ii) the date of the Company’s liquidation.

As of June 30, 2024 and December 31, 2023, there was $300,000 and $0 outstanding under the Extension Note.

Administrative Services Agreement

The Company entered into an Administrative Services Agreement with the Sponsor commencing on the date the securities of the Company are first listed on the Nasdaq Global Market, pursuant to a Registration Statement on Form S-1 filed by the Company with the SEC and continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation. The Company will pay $10,000 per month to the Sponsor for certain office space, utilities and secretarial and administrative services as may be reasonably required from time to time. As of June 30, 2024 and December 31, 2023, there is $60,000 and $116,129, respectively, in due to related party related to the agreement. The Company incurred $30,000 and $60,000, respectively for the three and six months ended June 30, 2024. The Company incurred $30,000 and $56,129, respectively for the three and six months ended June 30, 2023. Amounts have been included in administrative expense - related party in the statements of operations.

Note 5 – Commitments & Contingencies

Registration and Shareholder Rights

The holders of the Founder Shares, as well as the holders of the Private Units (and the underlying securities) and any units that may be issued in payment of Working Capital Loans made to Company, will be entitled to registration rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of a majority of the Private Units (and the underlying securities) and units issued in payment of Working Capital Loans (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

17

Underwriting Agreement

The Company granted the underwriters a 45- day option from the date of Initial Public Offering to purchase up to 1,875,000 additional Public Units to cover overallotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters exercised the option in full on January 18, 2023. The underwriters were entitled to a cash underwriting discount of $2,500,000, which was paid upon the closing of the Initial Public Offering. The underwriters are also entitled to a deferred cash underwriting discount of 3.50% of the gross proceeds of the Initial Public Offering and 5.50% of the gross proceeds from the sale of the Public Units sold pursuant to the over-allotment option, or $5,406,250, payable to the underwriters for deferred underwriting commissions. The full amount of the deferred cash underwriting discount was placed in the Trust Account and will be released to the underwriters only on, and concurrently with, the completion of an initial business combination.

Note 6 — Shareholders’ Equity (Deficit)

Preference shares - The Company is authorized to issue 2,000,000 preference shares with a par value of $0.0001 per preference share and with such designations, voting and other rights and preferences as may be determined from time to time by the Board. As of June 30, 2024 and December 31, 2023, there were no preference shares issued or outstanding.

Class A ordinary shares - The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per Class A ordinary share. In connection with the shareholders’ vote at an extraordinary general meeting of shareholders held on January 8, 2024 (the “Meeting”), holders of 7,115,385 Class A ordinary shares of the Company exercised their right to redeem such shares. Accordingly, as of June 30, 2024 and December 31, 2023, there were 762,500 Class A ordinary shares issued or outstanding, excluding 7,259,615 and 14,375,000 shares of Class A ordinary shares issued and outstanding subject to possible redemption, respectively.

Class B ordinary shares - The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per Class B ordinary share. Holders are entitled to one vote for each Class B ordinary share. As of June 30, 2024 and December 31, 2023, there were 4,791,667 Class B ordinary shares issued and outstanding.

On March 4, 2022, the Company effected a share capitalization with respect to our Class B ordinary shares of 1,150,000, resulting in our initial shareholders holding 6,900,000. On August 18, 2022, the Sponsor surrendered for no consideration 1,150,000 shares, resulting in a decrease in the total number of Class B shares outstanding to 5,750,000. On November 17, 2022 the Sponsor surrendered for no consideration 958,333 shares, resulting in a decrease in the total number of Class B shares outstanding to 4,791,667. All share amounts and related information have been retroactively restated in the financial statements to reflect the share capitalization and subsequent surrender.

Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company’s shareholders except as otherwise required by law.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Proposed Public Offering and related to the closing of the initial Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 25% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of the Proposed Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any private placement shares, any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment as provided above, at any time.

Warrants - Each whole redeemable warrant entitles the registered holder to purchase one whole Class A ordinary share at a price of  $11.50 per Class A ordinary share, subject to adjustment, at any time commencing 30 days after the completion of our initial business combination. The warrants will expire five years after the completion of the initial business combination, at 5:00 p.m., New York City time, or earlier upon the Company’s redemption or liquidation.

18

The Company agrees that as soon as practicable, but in no event later than 15 Business Days after the closing of its initial business combination, it shall use its commercially reasonable efforts to file with the SEC a registration statement (which may be, at the election of the Company, a post-effective amendment to the Registration Statement) for the registration, under the Securities Act, of the offer and sale of the ordinary shares issuable upon exercise of the warrants. The Company shall use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of that certain Warrant Agreement, by and between the Company and American Stock Transfer & Trust Company (“Warrant Agent”), dated January 12, 2023 (the “Warrant Agreement”). If any such registration statement has not been declared effective by the 60th Business Day following the closing of the initial business combination, holders of the Public Warrants shall have the right, during the period beginning on the 61st Business Day after the closing of the initial business combination and ending upon such registration statement being declared effective by the SEC, and during any other period when the Company shall fail to have maintained an effective registration statement, and current prospectus relating thereto, covering the offer and sale of the issuance of the ordinary shares issuable upon exercise of the Public Warrants, to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption for that number of shares of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of shares of ordinary shares underlying the Public Warrants, multiplied by the excess of the Fair Market Value (as defined below) less the Warrant Price (as defined in the Warrant Agreement) by (y) the Fair Market Value. The “Fair Market Value” shall mean the volume-weighted average price of the shares of ordinary shares as reported during the 10-trading-day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary. The date that notice of “cashless exercise” is received by the Warrant Agent shall be conclusively determined by the Warrant Agent.

Redemption of Warrants when the Price per Class A Ordinary Share Equals or Exceeds $18.00.

Once the warrants become exercisable, the Company may redeem all, but not less than all, of the Public Warrants:

Not earlier than 90 days after the completion of the initial business combination;
in whole and not in part;
at a price of $0.01 per warrant;
provided that the last reported sale price of the Class A ordinary shares for any 20 days within the 30-trading day period ending on the third trading date prior to the date on which notice of the redemption is given equals or exceeds $18.00 per Class A ordinary shares; and
either there is an effective registration statement covering the offer and sale of the issuance of the ordinary shares issuable upon exercise of the Public Warrants, and a current prospectus relating thereto, available throughout the 30-day redemption period; or
the Company has elected to require the exercise of the Public Warrants on a “cashless basis.”

If (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at an issue price or effective issue price of less than $9.20 per ordinary shares (with such issue price or effective issue price to be determined in good faith by the Board and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Class B ordinary shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial business combination on the date of the completion of the Company’s initial business combination (net of redemptions), and (z) the volume-weighted average trading price of shares of Class A ordinary shares during the 20-trading-day period starting on the trading day prior to the day on which the Company consummates its initial business combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described under “Redemption of warrants for cash” shall be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. If the adjustment in the immediately preceding sentence would otherwise result in an increase in the Warrant Price (as adjusted for share splits, share dividends, recapitalizations, extraordinary dividends and similar events) hereunder, no adjustment shall be made.

19

The Private Warrants are identical to the Public Warrants underlying the Public Units, except that the Private Warrants may be exercised for cash or on a “cashless basis,” the Private Warrants and the Class A ordinary shares issuable upon exercise of the Private Warrants may be subject to certain transfer restrictions, and the Private Warrants are not redeemable at the option of the Company. The Private Warrants shall not become Public Warrants as a result of any transfer of the Private Warrants, regardless of the transferee.

If a tender offer, exchange or redemption offer shall have been made to and accepted by the holders of the Class A ordinary shares and upon completion of such offer, the offeror owns beneficially more than 50% aggregate voting power, including the power to vote on the election of directors of the Company, of the issued and outstanding equity securities of the Company, the holder of a warrant shall be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such warrant had been exercised, accepted such offer and all of the Class A ordinary shares held by such holder had been purchased pursuant to the offer. If less than 70% of the consideration receivable by the holders of the Class A ordinary shares in the applicable event is payable in the form of common equity in the successor entity that is listed on a national securities exchange or is quoted in an established over-the-counter market, and if the holder of a warrant properly exercises such warrant within 30 days following the public disclosure of the consummation of the applicable event by the Company, the Warrant Price shall be reduced by an amount equal to the difference (but in no event less than zero) of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined in the Warrant Agreement) minus (B) the value of the warrant based on the Black-Scholes Warrant Value for a Capped American Call for Public Warrants and Uncapped American Call for Private Warrants on Bloomberg Financial Markets.

Note 7 — Fair Value Measurements

At June 30, 2024 and December 31, 2023, the Company’s cash and marketable securities held in the Trust Account were valued at $80,313,771 and $153,702,006, respectively. The cash and marketable securities held in the Trust Account must be recorded on the balance sheet at fair value and are subject to re-measurement at each balance sheet date. With each re-measurement, the valuations will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.

The following table presents the fair value information, as of June 30, 2024 and December 31 2023, of the Company’s financial assets that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. The Company’s cash and marketable securities held in the Trust Account are based on dividend and interest income and market fluctuations in the value of invested marketable securities, which are considered observable. The fair value of the marketable securities held in trust is classified within Level 1 of the fair value hierarchy.

The following table sets forth by level within the fair value hierarchy the Company’s assets and liabilities that were accounted for at fair value on a recurring basis:

June 30,2024

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets

 

  

 

  

 

  

Cash equivalents(1)

$

66,926

$

$

Cash and marketable securities held in Trust Account(2)

$

80,313,771

$

$

    

December 31, 2023

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets

  

 

  

 

  

Cash equivalents(1)

$

671,628

$

$

Cash and marketable securities held in Trust Account(2)

$

153,702,006

$

$

(1)The fair value of money market funds have been measured on a recurring basis using Level 1 inputs, which are based on unadjusted quoted market prices within active markets.
(2)The fair value of the marketable securities held in the Trust Account approximates the carrying amount primarily due to their short-term nature.

20

Measurement

The Company established the initial fair value for the cash and marketable securities held in the Trust Account on January 18, 2023, the date of the consummation of the Company’s Initial Public Offering. As the cash was transferred to the Trust Account on January 18, 2023, the value at that date is the value of the cash transferred. Changes in fair value will result from dividend and interest income and market fluctuations in the value of invested marketable securities which will be reflected on each month end bank statement.

Note 8 — Subsequent Events

On July 17, 2024, the Company drew an additional $50,000 against the Extension Note to extend the Termination Date to August 18, 2024.

Additionally, on July 17, 2024, the Company issued an unsecured promissory note to the Sponsor (the “July Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $1,500,000. The July Promissory Note bears no interest and is repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company’s initial business combination, or (ii) the date of the Company’s liquidation. As of August 14, 2024, there was $150,000 outstanding under the July Promissory Note.

21

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

We refer to this report as our “Quarterly Report on Form 10-Q” and references to “we,” “us” or the “Company” herein reference Israel Acquisitions Corp, a Cayman Islands exempted company. Reference to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Israel Acquisitions Sponsor LLC, a Delaware limited liability company. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form 10-Q. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (an “initial business combination”), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and “variations” and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of an initial business combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section in Item 1A. to Part I of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (our “Annual Report”), filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a newly organized blank check company incorporated on August 24, 2021, as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar combination with one or more businesses or assets, which we refer to throughout this Quarterly Report on Form 10-Q as our initial business combination. We have generated no revenues to date, and we do not expect that we will generate operating revenues at the earliest until we consummate our initial business combination. While we may pursue an initial business combination target in any industry or sector, we intend to focus our search on high-growth technology companies that are domiciled in Israel, that carry out all or a substantial portion of their activities in Israel, or that have some other significant Israeli connection.

Recent Developments

On January 2, 2024, we entered into the Business Combination Agreement with Pomvom Ltd. (“Pomvom”), pursuant to which, among other things and subject to the terms and conditions contained therein (i) Pomvom will cause a company organized under the laws of the State of Israel and wholly owned by a trustee (the “NewPubco”) to be formed, (ii) Pomvom will cause a Cayman Islands exempted company and wholly owned, direct subsidiary of NewPubco (“Merger Sub”) to be formed, (iii) Pomvom will cause NewPubco and Merger Sub to become a party to the Business Combination Agreement by delivering a joinder to the Business Combination Agreement, (iv) Pomvom will effect the Share Split (as defined below), (v) NewPubco, the shareholders of Pomvom and the holders of equity awards of Pomvom will effect the Equity Exchange (as defined below), and (vi) Merger Sub will merge with and into the Company, with the Company surviving the merger as a direct wholly owned subsidiary of NewPubCo (the “Merger”). The collective transactions referenced in (i)-(vi) are hereinafter referred to as the “Transactions”. The terms of the Business Combination Agreement, which contain customary representations and warranties, covenants, closing conditions, termination provisions, and other terms relating to the Merger, are summarized in the Recent Developments section in Item 2 to Part I of our Annual Report.

22

On January 18, 2024, the Company issued an unsecured promissory note to the Sponsor, to pay for up to twelve additional one-month extension payments (the “Extension Note”). On each of January 16, 2024, February 15, 2024, March 11, 2024, April 15, 2024, May 17, 2024, and June 14, 2024, the Company drew $50,000, $300,000 in the aggregate, against the Extension Note to pay for each additional one-month extension. The Extension Note bears no interest and is repayable in full (subject to amendment or waiver) upon the earlier of (a) the date of the consummation of the Company’s initial business combination, or (b) the date of the Company’s liquidation.

On April 22, 2024, we entered into an amendment with Pomvom (the “Amendment”) to the Business Combination Agreement. Pursuant to the Amendment, the we agreed with Pomvom to (i) extend the date by which all members of the board of directors of the post-combination company shall be agreed determined from April 30, 2024, to June 30, 2024, (ii) extend the date by which an independent compensation consultant shall present a benchmark analysis of the compensation packages for officers and directors of public market companies that are comparable to Pomvom and recommendations for officer and director compensation packages to the Pomvom’s compensation committee and board of directors in connection with their review and approval of such packages from April 30, 2024, to June 30, 2024, and (iii) extend the Minimum Equity Financing Proceeds Termination Date (as defined in the Business Combination Agreement) from June 30, 2024, to August 31, 2024.

On July 17, 2024, the Company issued an unsecured promissory note to the Sponsor (the “July Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $1,500,000. The July Promissory Note bears no interest and is repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company's initial business combination, or (ii) the date of the Company's liquidation. As of August 14, 2024, there was $150,000 outstanding under the July Promissory Note.

Results of Operations

As of June 30, 2024, we had not commenced any operations. All activity from inception through June 30, 2024, relates to our formation and initial public offering (the “Initial Public Offering”), and, since the completion of the Initial Public Offering, our search for a target to consummate a business combination. We will not generate any operating revenues until after the completion of an initial business combination, at the earliest. We will generate non-operating income in the form of interest and dividend income from the proceeds derived from the Initial Public Offering and placed in a U.S.-based trust account (the “Trust Account”). We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended June 30, 2024, we had net income of $738,891, which consisted of listing expenses of $4,425, administrative expenses of $36,004, legal and accounting expenses of $151,845, dues and subscriptions expense of $37,240, and insurance expense of $64,167, offset by dividends income on marketable securities held in the Trust Account of $1,031,091, and dividends and interest on cash and cash equivalents of $1,481. For the three months ended June 30, 2023, we had net income of $1,435,806, which consisted of listing expenses of $5,550, administrative expenses of $129,963, legal and accounting expenses of $115,887, dues and subscriptions expense of $3,198, and insurance expense of $64,167, offset by an unrealized gain and dividend income on marketable securities held in the Trust Account of $1,743,579, dividends and interest on cash and cash equivalents of $10,992.

For the six months ended June 30, 2024, we had net income of $1,314,747, which consisted of listing expenses of $121,889, administrative expenses of $73,033, legal and accounting expenses of $530,425, dues and subscriptions expense of $71,775, and insurance expenses of $128,334, offset by dividend income on marketable securities held in the Trust Account of $2,232,923, dividends and interest on cash and cash equivalents of $7,280. For the six months ended June 30, 2023, we had net income of $2,579,771, which consisted of listing expenses of $10,763, administrative expenses of $160,848, legal and accounting expenses of $244,071, marketing and advertising expense of $3,732, dues and subscriptions expense of $5,848, and insurance expense of $120,054, offset by an unrealized gain and dividend income on marketable securities held in the Trust Account of $3,102,894, dividends and interest on cash and cash equivalents of $22,193.

Liquidity, Capital Resources and Going Concern

As of June 30, 2024, we had $66,926 in cash and cash equivalents held outside of the Trust Account and a working capital deficit of $663,702 (excluding cash and marketable securities held in the Trust Account and the deferred underwriter fee payable).

23

Until the consummation of the Initial Public Offering, our only source of liquidity was from the $25,000 of proceeds from our sponsor’s purchase of Class B ordinary shares, par value $0.0001 per share, and a loan of $237,234 from our sponsor pursuant to a promissory note to cover certain expenses. The promissory note was repaid in full on January 18, 2023.

Following our Initial Public Offering and the sale of Private Placement Units (the “Private Units”) to the sponsor, a total of $146,625,000 was placed in the Trust Account.

For the six months ended June 30, 2024, net cash provided by operating activities was $1,628,221. Net income of $1,314,747 was adjusted by $313,474 changes in operating assets and liabilities. Net cash provided by investing activities was $73,388,235 related to proceeds from redemption of marketable securities held in Trust Account of $75,921,158, offset by the purchase of marketable securities held in Trust Account of $250,249, as well as dividends received from and reinvestment of marketable securities of $2,282,674. Net cash used in financing activities was $75,621,158 related to payment of redemptions on Class A ordinary shares subject to redemption of $75,921,158, offset by $300,000 of payments made by the Sponsor for Trust extension fees.

As of June 30, 2024, we had marketable securities held in the Trust Account of $80,313,771 (including approximately $2,232,923 of gains on marketable securities) consisting of securities held in a money market fund that invests in U.S. Treasury securities with a maturity of 185 days or less. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less deferred underwriting fees and income taxes payable), to complete our initial business combination. To the extent that our capital shares or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of June 30, 2024, we had cash and cash equivalents of $66,926 held outside the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.

We may need to raise additional funds in order to meet the expenditures required for operating our business prior to our initial business combination. We expect to incur significant costs related to identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination. These conditions raise substantial doubt about our ability to continue as a going concern for a period of time within one year from the date that the financial statements accompanying this Quarterly Report on Form 10-Q are issued.

In order to fund working capital deficiencies or finance transaction costs in connection with a business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a business combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a business combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units of the post-business combination entity at a price of $10.00 per unit, at the option of the lender. As of June 30, 2024, we did not have any outstanding working capital loans.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities as of June 30, 2024.

The underwriters of the Initial Public Offering are entitled to a deferred discount of $0.35 per Unit, or $5,406,250 in the aggregate. The deferred discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,

24

disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting estimates as of June 30, 2024.

Recent Accounting Pronouncements

In December 2023, the FASB issued Accounting Standards Update 2023-09, “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which provides for additional disclosures primarily related to the income tax rate reconciliations and income taxes paid. ASU 2023-09 requires entities to annually disclose the income tax rate reconciliation using both amounts and percentages, considering several categories of reconciling items, including state and local income taxes, foreign tax effects, tax credits and nontaxable or nondeductible items, among others. Disclosure of the reconciling items is subject to a quantitative threshold and disaggregation by nature and jurisdiction. ASU 2023-09 also requires entities to disclose net income taxes paid or received to federal, state and foreign jurisdictions, as well as by individual jurisdiction, subject to a five percent quantitative threshold. ASU 2023-09 may be adopted on a prospective or retrospective basis and is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2023-09 would have on its financial position, results of operations or cash flows.

The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

Item 4. Controls and Procedures Evaluation of Disclosure Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information that is required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer (who serves as our principal executive officer) and Chief Financial Officer (who serve as our principal financial and accounting officer), to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended June 30, 2024, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of June 30, 2024.

The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. However, management believes that our system of disclosure controls and procedures are designed to provide a reasonable level of assurance that the objectives of the system will be met.

25

Remediation of Previously Identified Material Weakness

As previously disclosed in Part II, Item 9A of our Annual Report on Form 10 - K for the year ended December 31, 2023, we identified a material weakness related to the fact that we have not yet designed and maintained effective controls relating to the accounting for offering costs related to the Company’s initial public offering. Specifically, certain accounting costs incurred through December 31, 2022 not directly or incrementally related to the initial public offering were incorrectly recorded as deferred offering costs rather than expensed as incurred. During 2023, we implemented a remediation plan, which included a control that our principal financial officer performing additional post-closing review procedures including consulting with subject matter experts related to the accounting for certain offering expenses. The Company completed testing over the design and operating effectiveness of the relevant control and concluded the material weakness was remediated as reported in the Company’s March 31,2024 Form 10-Q.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2024, covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

26

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1.A. Risk Factors

There have been no material changes to the Risk Factors previously disclosed in Item 1A. to Part I of our Annual Report  and the Risk Factors previously disclosed in Item 1.A. of our Quarterly Report on Form 10 - Q for the fiscal quarter ended March 31, 2024. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and/or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

As of the end of the fiscal quarter ended June 30, 2024, no director or officer of the Company adopted, modified, or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or any “non-Rule 10b5-1 arrangement” as defined in Item 408(c) of Regulation S-K.

27

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

 

 

 

Incorporated by Reference

Exhibit 
No.

    

Exhibit Description

  

Form

  

SEC File
No.

  

Exhibit

  

Filing
Date

2.1

Business Combination Agreement, dated as of January 2, 2024, by and between the Company and Pomvom Ltd.

8-K

001-41593

2.1

January 2, 2024

2.2

Amendment No. 1 to the Business Combination Agreement, dated April 22, 2024, between IAC and Pomvom.

8-K

001-41593

2.2

April 24, 2024

3.1

Third Amended and Restated Memorandum and Articles of Association, dated January 8, 2024.

8-K

001-41593

3.1

January 11, 2024

10.1*

Promissory Note, dated July 17, 2024, between the Company and Israel Acquisitions Sponsor LLC.

31.1*

 

Certification of Chief Executive Officer pursuant to Rules 13a 14(a) and 15d-14(a) under the Security Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

31.2*

 

Certification of Chief Financial Officer pursuant to Rules 13a 14(a) and 15d-14(a) under the Security Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

32.1**

 

Certification of Chief Executive Officer pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.

 

 

 

 

 

 

 

 

32.2**

 

Certification of Chief Financial Officer pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.

 

 

 

 

 

 

 

 

101.INS*

XBRL Instance Document

101.SCH*

XBRL Taxonomy Extension Schema Document

101.CAL*

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

 

XBRL Taxonomy Extension Labels Linkbase Document

 

 

 

 

 

 

 

 

101.PRE*

XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File. Formatted in Inline XBRL and contained in exhibit 101.

*

Filed herewith.

**

Furnished herewith.

28

PART III – SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ISRAEL ACQUISITIONS CORP

Date: August 14, 2024

By:

/s/ Ziv Elul

Name:

Ziv Elul

Title:

Chief Executive Officer and Director

(Principal Executive Officer)

Date: August 14, 2024

By:

/s/ Sharon Barzik Cohen

Name:

Sharon Barzik Cohen

Title:

Chief Financial Officer and Director

(Principal Financial and Accounting Officer)

29

EXHIBIT 10.1

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

PROMISSORY NOTE

Principal Amount: Up to $1,500,000

Dated as of July 17, 2024
New York, New York

Israel Acquisition Corp, an exempted limited company incorporated in the Cayman Islands and blank check company (“Maker”), promises to pay to the order of Israel Acquisitions Sponsor LLC, a Delaware limited liability company, or its registered assigns or successors in interest (“Payee”), or order, the unpaid Principal Amount (as defined herein) of up to One Million Five-Hundred Thousand Dollars ($1,500,000) in lawful money of the United States of America (the “Principal Amount”), on the terms and conditions described below to be used for the working capital of the Maker. All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by Maker to such account as Payee may from time to time designate by written notice in accordance with the provisions of this Note.

1. Principal. The entire unpaid principal balance under this Note shall be due and payable in full on the earlier of (i) the date on which Maker consummates its initial merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination (the “Business Combination”) and (ii) the date that the winding up of Maker is effective (such date, the “Maturity Date”), unless accelerated upon the occurrence of an Event of Default (as defined below). Any outstanding unpaid Principal Amount under this Note may be prepaid at any time by Maker, at its election and without penalty. Under no circumstances shall any individual, including, but not limited to, any officer, director, employee or shareholder of Maker, be obligated personally for any obligations or liabilities of Maker hereunder.

2. Interest. No interest shall accrue on the unpaid Principal Amount of this Note.

3. Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to the reduction of the unpaid Principal Amount of this Note.

4. Events of Default. The following shall constitute an event of default (“Event of Default”):

(a)  Failure to Make Required Payments. Failure by Maker to pay the unpaid Principal Amount due pursuant to this Note within five (5) business days of the Maturity Date.

(b)  Voluntary Bankruptcy, Etc. The commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

(c)  Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Maker in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official)

1


of Maker or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of sixty (60) consecutive days.

5. Remedies.

(a)  Upon the occurrence of an Event of Default specified in Section 4(a) hereof, Payee may, by written notice to Maker, declare this Note to be due and payable, whereupon the unpaid Principal Amount of this Note, and all other amounts payable hereunder, shall become immediately due and payable (to the extent of working capital available to Maker and unless otherwise satisfied) without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

(b)  Upon the occurrence of an Event of Default specified in Sections 4(b) and 4(c), the unpaid Principal Amount of, and all other sums payable with regard to, this Note, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee.

6. Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to this Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof or any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

7. Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder.

8. Notices. All notices, statements or other documents which are required or contemplated by this Note shall be made in writing and delivered: (i) personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax number as may be designated in writing by such party or (iii) by electronic mail, to the electronic mail address most recently provided to such party or such other electronic mail address as may be designated in writing by such party. Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days after mailing if sent by mail.

9. Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.

10. Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

11. Trust Waiver. Notwithstanding anything herein to the contrary, Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”) in or to any distribution of or from the Maker’s Trust Account (as defined in Maker’s Certificate of Incorporation), and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever.

2


12. Amendment; Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of Maker and Payee.

13. Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void. This Note shall be binding upon and benefit the permitted successors and permitted assigns of a party hereto.

[Signature Page Follows]

3


IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed by the undersigned as of the day and year first above written.

Israel Acquisition Corp

By:

/s/ Ziv Elul

Name: Ziv Elul

Title: Chief Executive Officer

Accepted and agreed,

Israel Acquisitions Sponsor LLC

By:

/s/ Alexander Greystoke

Name: Alexander Greystoke

Title: Manager

4


EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ziv Elul, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Israel Acquisitions Corp;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting

Date: August 14, 2024

/s/ Ziv Elul

Ziv Elul

Chief Executive Officer and Director

(Principal Executive Officer)


EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Sharon Barzik Cohen, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Israel Acquisitions Corp;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2024

/s/ Sharon Barzik Cohen

Sharon Barzik Cohen

Chief Financial Officer and Director

(Principal Financial and Accounting Officer)


EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Israel Acquisitions Corp (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission (the “Report”), I, Ziv Elul, Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 14, 2024

/s/ Ziv Elul

Ziv Elul

Chief Executive Officer and Director

(Principal Executive Officer)


EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Israel Acquisitions Corp (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission (the “Report”), I, Sharon Barzik Cohen, Chief Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 14, 2024

/s/ Sharon Barzik Cohen

Sharon Barzik Cohen

Chief Financial Officer and Director

(Principal Financial and Accounting Officer)


v3.24.2.u1
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2024
Aug. 14, 2024
Document Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2024  
Document Transition Report false  
Entity File Number 001-41593  
Entity Registrant Name ISRAEL ACQUISITIONS CORP  
Entity Incorporation, State or Country Code E9  
Entity Tax Identification Number 87-3587394  
Entity Address, Address Line One 12600 Hill Country Blvd, Building R  
Entity Address, Address Line Two Suite 275  
Entity Address, City or Town Bee Cave  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 78738  
City Area Code 800  
Local Phone Number 508-1531  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Entity Central Index Key 0001915328  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Units, each consisting of one Class A ordinary share and one redeemable warrant    
Document Entity Information    
Title of 12(b) Security Units, each consisting of one Class A ordinary share and one redeemable warrant  
Trading Symbol ISRLU  
Security Exchange Name NASDAQ  
Class A ordinary shares    
Document Entity Information    
Title of 12(b) Security Class A ordinary shares, par value $0.0001 per share  
Trading Symbol ISRL  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   8,022,115
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share    
Document Entity Information    
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share  
Trading Symbol ISRLW  
Security Exchange Name NASDAQ  
Common Class B    
Document Entity Information    
Entity Common Stock, Shares Outstanding   4,791,667
v3.24.2.u1
CONDENSED BALANCE SHEETS - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 66,926 $ 671,628
Prepaid expenses 70,056 145,114
Cash and Marketable Securities held in Trust Account 80,313,771 153,702,006
Total Current Assets 80,450,753 154,518,748
Total Assets 80,450,753 154,518,748
Current liabilities:    
Accrued expenses 314,186 55,000
Accounts payable 126,498 91,139
Due to related party $ 60,000 $ 116,129
Other Liability, Current, Related Party, Type [Extensible Enumeration] Related Party [Member] Related Party [Member]
Promissory note - related party $ 300,000  
Notes Payable, Current, Related Party, Type [Extensible Enumeration] Related Party [Member] Related Party [Member]
Deferred underwriting commissions $ 5,406,250 $ 5,406,250
Total Current Liabilities 6,206,934 5,668,518
Total Liabilities 6,206,934 5,668,518
Commitments and Contingencies (Note 5)
Shareholders' Deficit    
Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding
Accumulated deficit (6,070,507) (4,852,331)
Total Shareholders' Deficit (6,069,952) (4,851,776)
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT 80,450,753 154,518,748
Class A ordinary shares    
Shareholders' Deficit    
Ordinary shares 76 76
Class A ordinary shares subject to possible redemption    
Current liabilities:    
Class A ordinary shares subject to possible redemption, $0.0001 par value; 7,259,615 and 14,375,000 shares issued and outstanding at redemption value at June 30 , 2024 and December 31, 2023, respectively 80,313,771 153,702,006
Class B ordinary shares    
Shareholders' Deficit    
Ordinary shares $ 479 $ 479
v3.24.2.u1
CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2024
Dec. 31, 2023
Preference shares, par value (in dollars per share) $ 0.0001 $ 0.0001
Preference shares, share authorized 2,000,000 2,000,000
Preference shares, share issued 0 0
Preference shares, share outstanding 0 0
Class A ordinary shares    
Ordinary shares, Par value (in dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, share authorized 200,000,000 200,000,000
Class A ordinary shares subject to possible redemption    
Temporary equity, par value (in dollars per share) $ 0.0001 $ 0.0001
Temporary equity, shares issued 7,259,615 14,375,000
Temporary equity, shares outstanding 7,259,615 14,375,000
Class A ordinary shares not subject to possible redemption    
Ordinary shares, share issued 762,500 762,500
Ordinary shares, share outstanding 762,500 762,500
Class B ordinary shares    
Ordinary shares, Par value (in dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, share authorized 20,000,000 20,000,000
Ordinary shares, share issued 4,791,667 4,791,667
Ordinary shares, share outstanding 4,791,667 4,791,667
v3.24.2.u1
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Marketing and advertising expense       $ 3,732
Legal and accounting expense $ 151,845 $ 115,887 $ 530,425 244,071
Dues and subscriptions expense 37,240 3,198 71,775 5,848
Listing fee expense 4,425 5,550 121,889 10,763
Insurance expense 64,167 64,167 128,334 120,054
Loss from operations (293,681) (318,765) (925,456) (545,316)
Other income:        
Unrealized gain on marketable securities held in Trust Account   1,743,572   3,102,884
Dividend income on marketable securities held in Trust Account 1,031,091 7 2,232,923 10
Dividend income 1,480 10,991 7,278 22,073
Interest income 1 1 2 120
Other income, net 1,032,572 1,754,571 2,240,203 3,125,087
Net income 738,891 1,435,806 1,314,747 2,579,771
Nonrelated party        
Administrative expense 6,004 99,963 13,033 104,719
Related Party        
Administrative expense $ 30,000 $ 30,000 $ 60,000 $ 56,129
Class A ordinary shares subject to possible redemption        
Other income:        
Basic weighted average shares outstanding (in shares) 7,259,615 14,375,000 7,572,379 13,024,862
Diluted weighted average shares outstanding (in shares) 7,259,615 14,375,000 7,572,379 13,024,862
Basic net income (loss) per share (in dollars per share) $ 0.13 $ 0.11 $ 0.24 $ 0.46
Diluted net loss per share (in dollars per share) $ 0.13 $ 0.11 $ 0.24 $ 0.46
Non-redeemable Class A ordinary shares        
Other income:        
Basic weighted average shares outstanding (in shares) 762,500 762,500 762,500 690,884
Diluted weighted average shares outstanding (in shares) 762,500 762,500 762,500 690,884
Basic net income (loss) per share (in dollars per share) $ (0.03) $ (0.02) $ (0.10) $ (0.69)
Diluted net loss per share (in dollars per share) $ (0.03) $ (0.02) $ (0.10) $ (0.69)
Non-redeemable Class B ordinary shares        
Other income:        
Basic weighted average shares outstanding (in shares) 4,791,667 4,791,667 4,791,667 4,791,667
Diluted weighted average shares outstanding (in shares) 4,791,667 4,791,667 4,791,667 4,791,667
Basic net income (loss) per share (in dollars per share) $ (0.03) $ (0.02) $ (0.10) $ (0.62)
Diluted net loss per share (in dollars per share) $ (0.03) $ (0.02) $ (0.10) $ (0.62)
v3.24.2.u1
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT - USD ($)
Class A ordinary shares
Common Stock
Class A ordinary shares subject to possible redemption
Common Stock
Class A ordinary shares subject to possible redemption
Class A ordinary shares not subject to possible redemption
Common Stock
Class A ordinary shares not subject to possible redemption
Common Class B
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Increase (Decrease) in Temporary Equity                  
Issuance of Class A ordinary shares in initial public offering   $ 134,753,406              
Issuance of Class A ordinary shares in initial public offering (In shares)   14,375,000              
Balance at the end at Mar. 31, 2023   $ 147,984,315              
Balance at the end (in shares) at Mar. 31, 2023   14,375,000              
Balance at the beginning at Dec. 31, 2022           $ 479 $ 24,521 $ (77,000) $ (52,000)
Balance at the beginning (in shares) at Dec. 31, 2022           4,791,667      
Increase (Decrease) in Stockholders' Equity                  
Remeasurement of Class A ordinary shares to redemption value   $ 13,230,909         (8,003,804) (5,227,105) (13,230,909)
Issuance of Class A ordinary shares in initial public offering             354,359   354,359
Sale of private placement units       $ 76     7,624,924   7,625,000
Sale of private placement units (in shares)       762,500          
Net income (loss)               1,143,965 1,143,965
Balance at the end at Mar. 31, 2023       $ 76   $ 479   (4,160,140) (4,159,585)
Balance at the end (in shares) at Mar. 31, 2023       762,500   4,791,667      
Balance at the end at Jun. 30, 2023   $ 149,727,894              
Balance at the end (in shares) at Jun. 30, 2023   14,375,000              
Balance at the beginning at Dec. 31, 2022           $ 479 24,521 (77,000) (52,000)
Balance at the beginning (in shares) at Dec. 31, 2022           4,791,667      
Increase (Decrease) in Stockholders' Equity                  
Remeasurement of Class A ordinary shares to redemption value         $ (12,394,717)        
Net income (loss)                 2,579,771
Balance at the end at Jun. 30, 2023       $ 76   $ 479   (4,371,923) (4,371,368)
Balance at the end (in shares) at Jun. 30, 2023       762,500   4,791,667      
Balance at the beginning at Mar. 31, 2023   $ 147,984,315              
Balance at the beginning (in shares) at Mar. 31, 2023   14,375,000              
Balance at the end at Jun. 30, 2023   $ 149,727,894              
Balance at the end (in shares) at Jun. 30, 2023   14,375,000              
Balance at the beginning at Mar. 31, 2023       $ 76   $ 479   (4,160,140) (4,159,585)
Balance at the beginning (in shares) at Mar. 31, 2023       762,500   4,791,667      
Increase (Decrease) in Stockholders' Equity                  
Remeasurement of Class A ordinary shares to redemption value   $ 1,743,579         (95,990) (1,647,589) (1,743,579)
Transfer of Founder Shares             $ 95,990   95,990
Net income (loss)               1,435,806 1,435,806
Balance at the end at Jun. 30, 2023       $ 76   $ 479   (4,371,923) (4,371,368)
Balance at the end (in shares) at Jun. 30, 2023       762,500   4,791,667      
Balance at the beginning at Dec. 31, 2023   $ 153,702,006 $ 153,702,006            
Balance at the beginning (in shares) at Dec. 31, 2023   14,375,000 14,375,000            
Balance at the end at Mar. 31, 2024   $ 79,132,680              
Balance at the end (in shares) at Mar. 31, 2024   7,259,615              
Balance at the beginning at Dec. 31, 2023 $ 76         $ 479   (4,852,331) (4,851,776)
Balance at the beginning (in shares) at Dec. 31, 2023 762,500         4,791,667      
Increase (Decrease) in Stockholders' Equity                  
Remeasurement of Class A ordinary shares to redemption value   $ 1,351,832           (1,351,832) (1,351,832)
Redemption of Class A ordinary shares   $ (75,921,158)              
Redemption of Class A ordinary shares (in shares)   (7,115,385)              
Net income (loss)               575,856 575,856
Balance at the end at Mar. 31, 2024 $ 76         $ 479   (5,628,307) (5,627,752)
Balance at the end (in shares) at Mar. 31, 2024 762,500         4,791,667      
Balance at the beginning at Dec. 31, 2023   $ 153,702,006 $ 153,702,006            
Balance at the beginning (in shares) at Dec. 31, 2023   14,375,000 14,375,000            
Balance at the end at Jun. 30, 2024   $ 80,313,771 $ 80,313,771            
Balance at the end (in shares) at Jun. 30, 2024   7,259,615 7,259,615            
Balance at the beginning at Dec. 31, 2023 $ 76         $ 479   (4,852,331) (4,851,776)
Balance at the beginning (in shares) at Dec. 31, 2023 762,500         4,791,667      
Increase (Decrease) in Stockholders' Equity                  
Net income (loss)                 1,314,747
Balance at the end at Jun. 30, 2024 $ 76         $ 479   (6,070,507) (6,069,952)
Balance at the end (in shares) at Jun. 30, 2024 762,500         4,791,667      
Balance at the beginning at Mar. 31, 2024   $ 79,132,680              
Balance at the beginning (in shares) at Mar. 31, 2024   7,259,615              
Balance at the end at Jun. 30, 2024   $ 80,313,771 $ 80,313,771            
Balance at the end (in shares) at Jun. 30, 2024   7,259,615 7,259,615            
Balance at the beginning at Mar. 31, 2024 $ 76         $ 479   (5,628,307) (5,627,752)
Balance at the beginning (in shares) at Mar. 31, 2024 762,500         4,791,667      
Increase (Decrease) in Stockholders' Equity                  
Remeasurement of Class A ordinary shares to redemption value   $ 1,181,091           (1,181,091) (1,181,091)
Net income (loss)               738,891 738,891
Balance at the end at Jun. 30, 2024 $ 76         $ 479   $ (6,070,507) $ (6,069,952)
Balance at the end (in shares) at Jun. 30, 2024 762,500         4,791,667      
v3.24.2.u1
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash Flows from Operating Activities:    
Net income $ 1,314,747 $ 2,579,771
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Unrealized gain on marketable securities held in Trust Account   (3,102,884)
Excess fair value of transfer of Founder Shares   95,990
Changes in operating assets and liabilities:    
Prepaid expenses 75,058 (264,946)
Due to related party (56,129) 56,129
Accounts payable 35,359 48,455
Accrued expenses 259,186 (45,010)
Net cash provided by (used in) operating activities 1,628,221 (632,495)
Cash Flows from Investing Activities:    
Purchase and reinvestment of marketable securities held in Trust Account (2,532,923) (146,625,010)
Proceeds from redemption of marketable securities held in Trust Account 75,921,158  
Net cash provided by (used in) investing activities 73,388,235 (146,625,010)
Cash Flows from Financing Activities:    
Proceeds from issuance of ordinary shares   141,250,000
Proceeds from sale of private placement units   7,625,000
Payment of promissory note - related party   (237,234)
Payment of offering costs   (487,401)
Proceeds from promissory note - related party 300,000  
Redemptions of Class A ordinary shares subject to redemption (75,921,158)  
Net cash (used in) provided by financing activities (75,621,158) 148,150,365
Net Change in Cash and Cash Equivalents (604,702) 892,860
Cash and Cash Equivalents - Beginning 671,628 8,305
Cash and Cash Equivalents - Ending 66,926 901,165
Non-Cash Investing and Financing Activities:    
Remeasurement of Class A ordinary shares subject to possible redemption $ 2,532,923 14,974,488
Deferred underwriter fee payable   $ 5,406,250
v3.24.2.u1
Description of Organization, Business Operations and Liquidity and Capital Resources
6 Months Ended
Jun. 30, 2024
Description of Organization, Business Operations and Liquidity and Capital Resources  
Description of Organization, Business Operations and Liquidity and Capital Resources

Note 1 — Description of Organization, Business Operations and Liquidity and Capital Resources

Israel Acquisitions Corp (the “Company”) was incorporated as a blank check company in the Cayman Islands on August 24, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and is subject to all of the risks associated with emerging growth companies.

As of June 30, 2024, the Company had not commenced any operations. All activity for the period from August 24, 2021 (inception) through June 30, 2024 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), and, since the completion of the Initial Public Offering, a search for a target to consummate a Business Combination. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of gains on marketable securities held in the Trust Account, as well as interest and dividend income on cash and cash equivalents from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering was declared effective on January 12, 2023 (the “Registration Statement”). On January 18, 2023, the Company consummated its Initial Public Offering of 14,375,000 units (each a “Public Unit” and the “Public Units”) at $10.00 per Public Unit (including the issuance of 1,875,000 Public Units as a result of the underwriters’ exercise of heir over-allotment option in full), generating gross proceeds of $143,750,000, which is discussed in Note 3. Each Public Unit is comprised of one Class A ordinary share, par value $0.001 per share (each, a “Public Share” and the “Public Shares”) and one redeemable warrant evidencing the right to purchase one Class A ordinary share at a purchase price of $11.50 per Class A ordinary share (each a “Public Warrant” and the “Public Warrants”). Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 762,500 private placement units (each, a “Private Unit” and the “Private Units”) to Israel Acquisitions Sponsor LLC (the “Sponsor”), BTIG, LLC, Exos Capital LLC, and JonesTrading Institutional Services LLC, in a private placement at a purchase price of $10.00 per Private Unit, for an aggregate of $7,625,000. Each Private Unit is comprised of one Class A ordinary share, par value $0.001 per share (each, a “Private Share” and the “Private Shares”) and one redeemable warrant evidencing the right to purchase one Class A ordinary share, par value $0.0001 per share, at a purchase price of $11.50 (each, a “Private Warrant” and the “Private Warrants”).

Following the closing of the Initial Public Offering on January 18, 2023, $146,625,000 ($10.20 per Public Unit) from the net proceeds of the sale of the Public Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (“Trust Account”), located in the United States which will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of the Company’s initial business combination; (ii) the redemption of any Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association, adopted on November 17, 2022 (the “Amended and Restated Memorandum and Articles of Association”), and (iii) the redemption of the Company’s Public Shares if the Company is unable to complete an initial business combination by January 18, 2024 (or up to July 18, 2024, if the Company extends the time to complete an initial business combination) (the “Combination Period”).

On January 8, 2024, by special resolution and at an extraordinary general meeting of shareholders, the Company (i) entered into an amendment (the “Trust Agreement Amendment”) to the Invest Management Trust Agreement dated as of January 12, 2023 (the “Trust Agreement”), with Equiniti Trust Company, LLC (f/k/a American Stock Transfer & Trust Company) (the “Trustee”) and (ii) amended the Company’s Second Amended and Restated Memorandum and Articles of Association, in its entirety, by adopting the Company’s Third Amended and Restated Memorandum and Articles of Association, pursuant to which the Company may extend the date by which the Company must consummate an initial business combination (the “Termination Date”) from 12 months from the closing of the Initial Public Offering (January 18, 2024) up to twelve (12) times (each, an “Extension”) to January 18, 2025, with each Extension comprised of one month. Pursuant to the Trust Agreement Amendment, the Company can extend the Termination Date by providing five days’ advance notice to the Trustee prior to the applicable Extension and depositing into the Trust Account the lesser of (i) $50,000 or (ii) $0.02 per Public Share, multiplied by the number of Public Shares that remain outstanding by the end of the then-current extended period, by the date of such Extension.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating an initial business combination. There is no assurance that the Company will be able to complete an initial business combination successfully. The Company must complete an initial business combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial business combination. The Company will only complete an initial business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

The Company will provide its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of an initial business combination either (i) in connection with a shareholder meeting called to approve the initial business combination or (ii) by means of a tender offer. Except as required by law or the rules of Nasdaq, the decision as to whether the Company will seek shareholder approval of an initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account. There will be no redemption rights upon the completion of an initial business combination with respect to the Company’s warrants.

The Company will proceed with an initial business combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of an initial business combination and, if the Company seeks shareholder approval, a majority of the ordinary shares voted are voted in favor of the initial business combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing an initial business combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with an initial business combination, the Sponsor and our executive officers and directors have agreed (a) to vote their Founder Shares (as defined in this Note 1), Private Shares, and any Public Shares purchased during or after the Initial Public Offering in favor of approving an initial business combination and (b) not to convert any Founder Shares, Private Shares, or any Public Shares held by them in connection with a shareholder vote to approve an initial business combination or sell any such shares to the Company in a tender offer in connection with an initial business combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.

The Sponsor and our executive officers and directors have agreed (a) to waive their respective redemption rights with respect to any Founder Shares, Private Shares, or Public Shares held by them in connection with the completion of an initial business combination, (b) to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Shares if the Company fails to consummate an initial business combination, and (c) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association that would affect a public shareholders’ ability to convert or sell their Public Shares to the Company in connection with an initial business combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete an initial business combination, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

If the Company is unable to complete an initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors (the “Board”), dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s Public Warrants or Private Warrants, which will expire worthless if the Company fails to complete an initial business combination within the Combination Period.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.20 per Public Share, except as to any claims by a third party that executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Business Combination Agreement

On January 2, 2024, the Company entered into a business combination agreement with Pomvom Ltd., a company organized under the laws of Israel (“Pomvom,” and such agreement, the “Business Combination Agreement”), pursuant to which, among other things and subject to the terms and conditions contained therein (i) Pomvom will cause a company organized under the laws of the State of Israel and wholly owned by a trustee (the “NewPubCo”) to be formed, (ii) Pomvom will cause a Cayman Islands exempted company and wholly owned, direct subsidiary of NewPubco (“Merger Sub”) to be formed, (iii) Pomvom will cause NewPubCo and Merger Sub to become a party to the Business Combination Agreement by delivering a joinder to the Business Combination Agreement, (iv) Pomvom will effect the Share Split (as defined therein), (v) NewPubco, the shareholders of Pomvom and the holders of equity awards of Pomvom will effect the Equity Exchange (as defined therein), and (vi) Merger Sub will merge with and into the Company, with the Company surviving the merger as a direct wholly owned subsidiary of NewPubCo (the “Merger”).

On April 22, 2024, we entered into an amendment with Pomvom (the “Amendment”) to the Business Combination Agreement. Pursuant to the Amendment, the we agreed with Pomvom to (i) extend the date by which all members of the board of directors of the post-combination company shall be agreed determined from April 30, 2024, to June 30, 2024, (ii) extend the date by which an independent compensation consultant shall present a benchmark analysis of the compensation packages for officers and directors of public market companies that are comparable to Pomvom and recommendations for officer and director compensation packages to the Pomvom’s compensation committee and board of directors in connection with their review and approval of such packages from April 30, 2024, to June 30, 2024, and (iii) extend the Minimum Equity Financing Proceeds Termination Date (as defined in the Business Combination Agreement) from June 30, 2024, to August 31, 2024.

Liquidity Capital Resources and Going Concern

As of June 30, 2024, the Company had $66,926 in its operating bank account and a working capital deficit of $663,702 (excluding cash and marketable securities held in the Trust Account and the deferred underwriter fee payable) compared to $671,628 in its operating bank account and working capital of $554,474 (excluding cash and marketable securities held in the Trust Account and the deferred underwriter fee payable) as of December 31, 2023.

The Company’s liquidity needs through June 30, 2024 had been satisfied through a payment from the Sponsor of $25,000 for Class B ordinary shares, par value $0.0001 per share (the “Class B ordinary shares” or the “Founder Shares”), the Initial Public Offering and the issuance of the Private Units (see Note 3 and Note 4). Additionally, the Company drew on the Promissory Note (as defined below) to pay certain offering costs (see Note 4).

The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company lacks the financial resources it needs to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. Although no formal agreement exists, the Sponsor is committed to extend Working Capital Loans as needed (defined in Note 4 below). Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that (i) new financing will be available to it on commercially acceptable terms, if at all, or (ii) that its plans to consummate an initial business combination will be successful. In addition, management is currently evaluating the impact of the invasion of Ukraine by Russia, the increased rate of inflation in the United States and other events (such as terrorist attacks, natural disasters or a significant outbreak of other infectious diseases) on the industry and its effect on the Company’s financial position, results of its operations and/or search for a target company.

We may need to obtain additional financing to complete our initial business combination, either because the transaction requires more cash than is available from the proceeds held in our Trust Account, or because we become obligated to redeem a significant number of our public shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such initial business combination. If we have not consummated our initial business combination within the Combination Period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account.

These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern one year from the date the financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Risks and Uncertainties

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and/or search for a target company is also not determinable as of the date of these financial statements.

In October 2023, Hamas conducted several terrorist attacks in Israel resulting in ongoing war across the country, forcing the closure of many businesses in Israel for several days. In addition, there continue to be hostilities between Israel and Hezbollah in Lebanon and Hamas in the Gaza Strip, both of which resulted in rockets being fired into Israel, causing casualties and disruption of economic activities. In early 2023, there were a number of changes proposed to the political system in Israel by the current government which, if implemented as planned, could lead to large-scale protests and additional uncertainty, negatively impacting the operating environment in Israel. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and/or search for a target company is also not determinable as of the date of these financial statements.

The specific impact of these ongoing events is not readily determinable as of the date of these financial statements and these financial statements do not include any adjustments that may result from the outcomes of these uncertainties.

v3.24.2.u1
Significant Accounting Policies
6 Months Ended
Jun. 30, 2024
Significant Accounting Policies  
Significant Accounting Policies

Note 2 - Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, the financial statements do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2023 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The interim results for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future interim periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies.

The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statement in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of June 30, 2024 and December 31, 2023, the Company had $66,926 and $671,628 in cash and cash equivalents, respectively.

Cash and Marketable Securities held in Trust Account

Following the closing of the Initial Public Offering on January 18, 2023, an amount of $146,625,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units were placed in the Trust Account and may be invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Trust Account is intended as a holding place for funds pending the earliest to occur of: (i) the completion of the initial Business Combination; (ii) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination within 12 months from the closing of the Initial Public Offering or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within 12 months from the closing of the Initial Public Offering, the return of the funds held in the Trust Account to the public shareholders as part of redemption of the public shares.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2024 and December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2024, 7,259,615 Class A ordinary shares subject to possible redemption are presented as temporary equity, at redemption value, as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit.

The Class A ordinary shares subject to possible redemption is reflected on the balance sheet at June 30, 2024 as follows:

Gross proceeds from Initial Public Offering

    

$

143,750,000

Less:

 

Proceeds allocated to public warrants

 

(354,359)

Offering costs allocated to Class A ordinary shares subject to possible redemption

 

(8,642,235)

Plus:

 

Accretion of Class A ordinary shares subject to possible redemption

 

18,948,600

Class A ordinary shares subject to possible redemption at December 31, 2023

153,702,006

Redemption of Class A ordinary shares

(75,921,158)

Re-measurement of Class A ordinary shares subject to possible redemption

2,532,923

Class A ordinary shares subject to possible redemption at June 30, 2024

$

80,313,771

Offering Costs associated with the Initial Public Offering

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of Offering”. Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. The Company incurred offering costs from the Initial Public Offering of $8,642,235, consisting of $2,500,000 of underwriting fee, $5,406,250 of deferred underwriting fee, $735,985 of actual offering costs. These amounts were recorded to additional paid-in capital as a reduction to the net proceeds from the offering.

Fair Value Measurements

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurements and Disclosures” (“ASC 820”), defines fair value as the amount that would be received to sell an asset or paid to transfer a liability, in an orderly transaction between market participants. Fair value measurements are classified on a three-tier hierarchy as follows:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. ln those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

The fair value of the Company’s assets and liabilities that qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Financial Instruments

The fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Derivative Financial Instruments

The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period. There were no derivative financial instruments accounted for as liabilities as of June 30, 2024 and December 31, 2023.

Warrants

The Company accounts for the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in FASB ASC Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). Pursuant to the Company’s evaluation, the Company concluded that the public and private do not meet the criteria to be accounted for as liability under ASC 480. The Company further evaluated the public and private warrants and rights under “ASC 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity” (“ASC 815-40”) and concluded that the public warrants, private placement warrants are indexed to the Company’s own stock and meet the criteria to be classified in shareholders’ equity.

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” (“ASC 740”) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2024 and December 31, 2023. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company is not currently aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to tax examinations by major taxing authorities since inception. There is currently no taxation imposed by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

There is currently no taxation imposed by the government of the Cayman Islands. The Company has no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. Consequently, income taxes are not reflected in the Company’s financial statement.

Net Income (Loss) Per Ordinary Share

The statement of operations includes a presentation of income (loss) per Class A redeemable ordinary share and income (loss) per non-redeemable ordinary share following the two-class method of income per ordinary share. In order to determine the net income (loss) attributable to both the Class A redeemable ordinary shares and non-redeemable ordinary shares, the Company first considered the total net income (loss) allocable to both sets of shares. This is calculated using the total net income (loss) less any dividends paid. For purposes of calculating net income (loss) per share, any remeasurement of the Class A ordinary shares subject to possible redemption was treated as dividends paid to the public shareholders.

Net income (loss) per ordinary share is computed by dividing net income (loss) by class by the weighted average number of ordinary shares outstanding during the period. The Company has not considered the effect of the 14,375,000 Public Warrants in the calculation of diluted net income (loss) per share, since the exercise of such warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the three months ended June 30, 2024 (in dollars, except share amounts):

    

Three Months Ended

June 30, 2024

Net income

$

738,891

Accretion of temporary equity to redemption value

 

(1,181,091)

Net loss including accretion of temporary equity to redemption value

$

(442,200)

Three Months Ended

June 30, 2024

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

418,616

$

43,969

$

276,306

Less: Accretion allocation based on ownership percentage

$

(669,144)

$

(70,282)

(441,665)

Allocation of accretion of temporary equity to redeemable shares

1,181,091

Total net income (loss) by class

$

930,563

$

(26,313)

(165,359)

Denominator:

Weighted average shares outstanding

7,259,615

762,500

4,791,667

Basic and diluted net income (loss) per share

$

0.13

$

(0.03)

(0.03)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the six months ended June 30, 2024 (in dollars, except share amounts):

    

Six Months Ended

June, 2024

Net income

$

1,314,747

Accretion of temporary equity to redemption value

 

(2,532,923)

Net loss including accretion of temporary equity to redemption value

$

(1,218,176)

Six Months Ended

June 30, 2024

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

744,866

$

78,236

$

491,645

Less: Accretion allocation based on ownership percentage

$

(1,435,021)

$

(150,725)

 

(947,177)

Allocation of accretion of temporary equity to redeemable shares

 

2,532,923

 

 

Total net income (loss) by class

$

1,842,768

$

(72,489)

 

(455,532)

Denominator:

 

  

 

  

 

  

Weighted average shares outstanding

 

7,572,379

 

762,500

 

4,791,667

Basic and diluted net income (loss) per share

$

0.24

$

(0.10)

 

(0.10)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the three months ended June 30, 2023 (in dollars, except share amounts):

    

Three Months Ended

June 30, 2023

Net income

$

1,435,806

Accretion of temporary equity to redemption value

 

(1,743,579)

Net loss including accretion of temporary equity to redemption value

$

(307,773)

Three Months Ended

June 30, 2023

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

1,035,653

$

54,935

$

345,218

Less: Accretion allocation based on ownership percentage

$

(1,257,652)

$

(66,710)

 

(419,217)

Allocation of accretion of temporary equity to redeemable shares

 

1,743,579

 

 

Total net income (loss) by class

$

1,521,580

$

(11,775)

 

(73,999)

Denominator:

 

  

 

  

 

  

Weighted average shares outstanding

 

1,437,000

 

762,500

 

4,791,667

Basic and diluted net income per share

$

0.11

$

(0.02)

 

(0.02)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the six months ended June 30, 2023 (in dollars, except share amounts):

    

Six Months Ended

June 30, 2023

Net loss from beginning on the year to date of initial public offering

$

(6,646)

Net income from date of initial public offering to period end

 

2,586,417

Total income for the three months ended June 30, 2023

 

2,579,771

Accretion of temporary equity to redemption value

 

(14,974,488)

Net loss including accretion of temporary equity to redemption value

$

(12,394,717)

    

Six Months Ended

June 30, 2023

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

  

 

  

Numerator:

 

  

  

 

  

Allocation of net loss from inception to date of initial public offering

$

$

$

(6,646)

Allocation of net income from date of initial public offering to period end

1,865,594

98,958

621,865

Total income allocated by class

1,865,594

98,958

615,219

Less: Accretion allocation based on ownership percentage

$

(10,801,168)

$

(572,931)

(3,600,389)

Allocation of accretion of temporary equity to redeemable shares

14,974,488

Total net income (loss) by class

$

6,038,914

$

(473,973)

(2,985,170)

Denominator:

Weighted average shares outstanding

13,024,862

690,884

4,791,667

Basic and diluted net income per share

$

0.46

$

(0.69)

(0.62)

Recent Accounting Pronouncements

In December 2023, the FASB issued Accounting Standards Update 2023-09, “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which provides for additional disclosures primarily related to the income tax rate reconciliations and income taxes paid. ASU 2023-09 requires entities to annually disclose the income tax rate reconciliation using both amounts and percentages, considering several categories of reconciling items, including state and local income taxes, foreign tax effects, tax credits and nontaxable or nondeductible items, among others. Disclosure of the reconciling items is subject to a quantitative threshold and disaggregation by nature and jurisdiction. ASU 2023-09 also requires entities to disclose net income taxes paid or received to federal, state and foreign jurisdictions, as well as by individual jurisdiction, subject to a five percent quantitative threshold. ASU 2023-09 may be adopted on a prospective or retrospective basis and is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2023-09 would have on its financial position, results of operations or cash flows.

The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying financial statements.

v3.24.2.u1
Initial Public Offering
6 Months Ended
Jun. 30, 2024
Initial Public Offering  
Initial Public Offering

Note 3 - Initial Public Offering

On January 18, 2023 the Company sold 14,375,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A ordinary share and one warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $11.50 per share (see Note 6).

An aggregate of $10.20 per Unit sold in the Initial Public Offering was deposited in the Trust Account and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. As of June 30, 2024, $80,313,771 was held in the Trust Account. In addition, $66,926 of operating cash is not held in the Trust Account and is available for working capital purposes.

v3.24.2.u1
Related Party Transactions
6 Months Ended
Jun. 30, 2024
Related Party Transactions  
Related Party Transactions

Note 4 - Related Party Transactions

Founder Shares

On January 26, 2022, the Sponsor purchased 5,750,000 shares (the “Founder Shares”) of the Company’s Class B ordinary shares, par value $0.0001 (“Class B ordinary shares”) for an aggregate price of $25,000.

On March 4, 2022, the Company effected a share capitalization with respect to our Class B ordinary shares of 1,150,000, resulting in our initial shareholders holding 6,900,000 shares. On August 18, 2022, the Sponsor surrendered for no consideration 1,150,000 shares, resulting in a decrease in the total number of Class B shares outstanding to 5,750,000. On November 17, 2022 the Sponsor surrendered for no consideration 958,333 shares, resulting in a decrease in the total number of Class B shares outstanding to 4,791,667. All share and per-share amounts have been retroactively restated.

On May 7, 2023, the Sponsor transferred 95,500 of its Founder Shares to our special advisor for consulting services. The consulting services offered were considered a benefit that the Company realized as a result of the Sponsors transaction with the special advisor. The fair value of the consulting services was determined to be a financing expense in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 718.

The Founder Shares will automatically convert into Class A ordinary shares at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions, as described in Note 6. Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment, at any time.

Private Placement

The Sponsor, BTIG, LLC, Exos Capital LLC, and JonesTrading Institutional Services LLC purchased an aggregate of 762,500 Private Units at a price of $10.00 per Private Unit for an aggregate purchase price of $7,625,000 in a private placement that occurred simultaneously with the closing of the Initial Public Offering, the proceeds of which were recorded in additional paid in capital. Each Private Unit consists of one share of Class A ordinary share (“Private Share”) and one warrant (“Private Warrant”). Each Private Warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $11.50 per full share, subject to adjustment. The proceeds from the Private Units were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

Related Party Loans

In addition, to finance transaction costs in connection with an initial business combination, the initial shareholders, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes an initial business combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that an initial business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of an initial business combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into private placement-equivalent units of the post initial business combination entity at a price of $10.00 per private placement-equivalent unit. These units would be identical to the Private Units. As of June 30, 2024 and December 31, 2023, the Company had no outstanding Working Capital Loans.

Promissory Note – Related Party

On January 26, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. As of January 18, 2023, the Company had borrowed $237,234 under the Promissory Note. On January 18, 2023 the Company paid $245,540 to the Sponsor, resulting in an overpayment of $8,306 that was recorded as a related party receivable, which was subsequently refunded to the Company prior to December 31, 2023. The Promissory Note was non-interest bearing. As of June 30, 2024 and December 31, 2023, the outstanding balance under the Promissory Note was $0.

On January 18, 2024, the Company issued a promissory note in the amount of $600,000 to pay for up to twelve additional one-month extension payments (the “Extension Note”). On each of January 16, 2024, February 15, 2024, March 11, 2024, April 15, 2024, May 17, 2024, and June 14, 2024, the Company drew $50,000, $300,000 in the aggregate, against the Extension Note to pay for each additional one-month extension. The Extension Note bears no interest and is repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company’s initial business combination, or (ii) the date of the Company’s liquidation.

As of June 30, 2024 and December 31, 2023, there was $300,000 and $0 outstanding under the Extension Note.

Administrative Services Agreement

The Company entered into an Administrative Services Agreement with the Sponsor commencing on the date the securities of the Company are first listed on the Nasdaq Global Market, pursuant to a Registration Statement on Form S-1 filed by the Company with the SEC and continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation. The Company will pay $10,000 per month to the Sponsor for certain office space, utilities and secretarial and administrative services as may be reasonably required from time to time. As of June 30, 2024 and December 31, 2023, there is $60,000 and $116,129, respectively, in due to related party related to the agreement. The Company incurred $30,000 and $60,000, respectively for the three and six months ended June 30, 2024. The Company incurred $30,000 and $56,129, respectively for the three and six months ended June 30, 2023. Amounts have been included in administrative expense - related party in the statements of operations.

v3.24.2.u1
Commitments & Contingencies
6 Months Ended
Jun. 30, 2024
Commitments & Contingencies  
Commitments & Contingencies

Note 5 – Commitments & Contingencies

Registration and Shareholder Rights

The holders of the Founder Shares, as well as the holders of the Private Units (and the underlying securities) and any units that may be issued in payment of Working Capital Loans made to Company, will be entitled to registration rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of a majority of the Private Units (and the underlying securities) and units issued in payment of Working Capital Loans (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45- day option from the date of Initial Public Offering to purchase up to 1,875,000 additional Public Units to cover overallotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters exercised the option in full on January 18, 2023. The underwriters were entitled to a cash underwriting discount of $2,500,000, which was paid upon the closing of the Initial Public Offering. The underwriters are also entitled to a deferred cash underwriting discount of 3.50% of the gross proceeds of the Initial Public Offering and 5.50% of the gross proceeds from the sale of the Public Units sold pursuant to the over-allotment option, or $5,406,250, payable to the underwriters for deferred underwriting commissions. The full amount of the deferred cash underwriting discount was placed in the Trust Account and will be released to the underwriters only on, and concurrently with, the completion of an initial business combination.

v3.24.2.u1
Shareholders' Equity (Deficit)
6 Months Ended
Jun. 30, 2024
Shareholders' Equity (Deficit)  
Shareholders' Equity (Deficit)

Note 6 — Shareholders’ Equity (Deficit)

Preference shares - The Company is authorized to issue 2,000,000 preference shares with a par value of $0.0001 per preference share and with such designations, voting and other rights and preferences as may be determined from time to time by the Board. As of June 30, 2024 and December 31, 2023, there were no preference shares issued or outstanding.

Class A ordinary shares - The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per Class A ordinary share. In connection with the shareholders’ vote at an extraordinary general meeting of shareholders held on January 8, 2024 (the “Meeting”), holders of 7,115,385 Class A ordinary shares of the Company exercised their right to redeem such shares. Accordingly, as of June 30, 2024 and December 31, 2023, there were 762,500 Class A ordinary shares issued or outstanding, excluding 7,259,615 and 14,375,000 shares of Class A ordinary shares issued and outstanding subject to possible redemption, respectively.

Class B ordinary shares - The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per Class B ordinary share. Holders are entitled to one vote for each Class B ordinary share. As of June 30, 2024 and December 31, 2023, there were 4,791,667 Class B ordinary shares issued and outstanding.

On March 4, 2022, the Company effected a share capitalization with respect to our Class B ordinary shares of 1,150,000, resulting in our initial shareholders holding 6,900,000. On August 18, 2022, the Sponsor surrendered for no consideration 1,150,000 shares, resulting in a decrease in the total number of Class B shares outstanding to 5,750,000. On November 17, 2022 the Sponsor surrendered for no consideration 958,333 shares, resulting in a decrease in the total number of Class B shares outstanding to 4,791,667. All share amounts and related information have been retroactively restated in the financial statements to reflect the share capitalization and subsequent surrender.

Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company’s shareholders except as otherwise required by law.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Proposed Public Offering and related to the closing of the initial Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 25% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of the Proposed Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any private placement shares, any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment as provided above, at any time.

Warrants - Each whole redeemable warrant entitles the registered holder to purchase one whole Class A ordinary share at a price of  $11.50 per Class A ordinary share, subject to adjustment, at any time commencing 30 days after the completion of our initial business combination. The warrants will expire five years after the completion of the initial business combination, at 5:00 p.m., New York City time, or earlier upon the Company’s redemption or liquidation.

The Company agrees that as soon as practicable, but in no event later than 15 Business Days after the closing of its initial business combination, it shall use its commercially reasonable efforts to file with the SEC a registration statement (which may be, at the election of the Company, a post-effective amendment to the Registration Statement) for the registration, under the Securities Act, of the offer and sale of the ordinary shares issuable upon exercise of the warrants. The Company shall use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of that certain Warrant Agreement, by and between the Company and American Stock Transfer & Trust Company (“Warrant Agent”), dated January 12, 2023 (the “Warrant Agreement”). If any such registration statement has not been declared effective by the 60th Business Day following the closing of the initial business combination, holders of the Public Warrants shall have the right, during the period beginning on the 61st Business Day after the closing of the initial business combination and ending upon such registration statement being declared effective by the SEC, and during any other period when the Company shall fail to have maintained an effective registration statement, and current prospectus relating thereto, covering the offer and sale of the issuance of the ordinary shares issuable upon exercise of the Public Warrants, to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption for that number of shares of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of shares of ordinary shares underlying the Public Warrants, multiplied by the excess of the Fair Market Value (as defined below) less the Warrant Price (as defined in the Warrant Agreement) by (y) the Fair Market Value. The “Fair Market Value” shall mean the volume-weighted average price of the shares of ordinary shares as reported during the 10-trading-day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary. The date that notice of “cashless exercise” is received by the Warrant Agent shall be conclusively determined by the Warrant Agent.

Redemption of Warrants when the Price per Class A Ordinary Share Equals or Exceeds $18.00.

Once the warrants become exercisable, the Company may redeem all, but not less than all, of the Public Warrants:

Not earlier than 90 days after the completion of the initial business combination;
in whole and not in part;
at a price of $0.01 per warrant;
provided that the last reported sale price of the Class A ordinary shares for any 20 days within the 30-trading day period ending on the third trading date prior to the date on which notice of the redemption is given equals or exceeds $18.00 per Class A ordinary shares; and
either there is an effective registration statement covering the offer and sale of the issuance of the ordinary shares issuable upon exercise of the Public Warrants, and a current prospectus relating thereto, available throughout the 30-day redemption period; or
the Company has elected to require the exercise of the Public Warrants on a “cashless basis.”

If (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at an issue price or effective issue price of less than $9.20 per ordinary shares (with such issue price or effective issue price to be determined in good faith by the Board and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Class B ordinary shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial business combination on the date of the completion of the Company’s initial business combination (net of redemptions), and (z) the volume-weighted average trading price of shares of Class A ordinary shares during the 20-trading-day period starting on the trading day prior to the day on which the Company consummates its initial business combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described under “Redemption of warrants for cash” shall be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. If the adjustment in the immediately preceding sentence would otherwise result in an increase in the Warrant Price (as adjusted for share splits, share dividends, recapitalizations, extraordinary dividends and similar events) hereunder, no adjustment shall be made.

The Private Warrants are identical to the Public Warrants underlying the Public Units, except that the Private Warrants may be exercised for cash or on a “cashless basis,” the Private Warrants and the Class A ordinary shares issuable upon exercise of the Private Warrants may be subject to certain transfer restrictions, and the Private Warrants are not redeemable at the option of the Company. The Private Warrants shall not become Public Warrants as a result of any transfer of the Private Warrants, regardless of the transferee.

If a tender offer, exchange or redemption offer shall have been made to and accepted by the holders of the Class A ordinary shares and upon completion of such offer, the offeror owns beneficially more than 50% aggregate voting power, including the power to vote on the election of directors of the Company, of the issued and outstanding equity securities of the Company, the holder of a warrant shall be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such warrant had been exercised, accepted such offer and all of the Class A ordinary shares held by such holder had been purchased pursuant to the offer. If less than 70% of the consideration receivable by the holders of the Class A ordinary shares in the applicable event is payable in the form of common equity in the successor entity that is listed on a national securities exchange or is quoted in an established over-the-counter market, and if the holder of a warrant properly exercises such warrant within 30 days following the public disclosure of the consummation of the applicable event by the Company, the Warrant Price shall be reduced by an amount equal to the difference (but in no event less than zero) of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined in the Warrant Agreement) minus (B) the value of the warrant based on the Black-Scholes Warrant Value for a Capped American Call for Public Warrants and Uncapped American Call for Private Warrants on Bloomberg Financial Markets.

v3.24.2.u1
Fair Value Measurements
6 Months Ended
Jun. 30, 2024
Fair Value Measurements  
Fair Value Measurements

Note 7 — Fair Value Measurements

At June 30, 2024 and December 31, 2023, the Company’s cash and marketable securities held in the Trust Account were valued at $80,313,771 and $153,702,006, respectively. The cash and marketable securities held in the Trust Account must be recorded on the balance sheet at fair value and are subject to re-measurement at each balance sheet date. With each re-measurement, the valuations will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.

The following table presents the fair value information, as of June 30, 2024 and December 31 2023, of the Company’s financial assets that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. The Company’s cash and marketable securities held in the Trust Account are based on dividend and interest income and market fluctuations in the value of invested marketable securities, which are considered observable. The fair value of the marketable securities held in trust is classified within Level 1 of the fair value hierarchy.

The following table sets forth by level within the fair value hierarchy the Company’s assets and liabilities that were accounted for at fair value on a recurring basis:

June 30,2024

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets

 

  

 

  

 

  

Cash equivalents(1)

$

66,926

$

$

Cash and marketable securities held in Trust Account(2)

$

80,313,771

$

$

    

December 31, 2023

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets

  

 

  

 

  

Cash equivalents(1)

$

671,628

$

$

Cash and marketable securities held in Trust Account(2)

$

153,702,006

$

$

(1)The fair value of money market funds have been measured on a recurring basis using Level 1 inputs, which are based on unadjusted quoted market prices within active markets.
(2)The fair value of the marketable securities held in the Trust Account approximates the carrying amount primarily due to their short-term nature.

Measurement

The Company established the initial fair value for the cash and marketable securities held in the Trust Account on January 18, 2023, the date of the consummation of the Company’s Initial Public Offering. As the cash was transferred to the Trust Account on January 18, 2023, the value at that date is the value of the cash transferred. Changes in fair value will result from dividend and interest income and market fluctuations in the value of invested marketable securities which will be reflected on each month end bank statement.

v3.24.2.u1
Subsequent Events
6 Months Ended
Jun. 30, 2024
Subsequent Events  
Subsequent Events

Note 8 — Subsequent Events

On July 17, 2024, the Company drew an additional $50,000 against the Extension Note to extend the Termination Date to August 18, 2024.

Additionally, on July 17, 2024, the Company issued an unsecured promissory note to the Sponsor (the “July Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $1,500,000. The July Promissory Note bears no interest and is repayable in full (subject to amendment or waiver) upon the earlier of (i) the date of the consummation of the Company’s initial business combination, or (ii) the date of the Company’s liquidation. As of August 14, 2024, there was $150,000 outstanding under the July Promissory Note.

v3.24.2.u1
Pay vs Performance Disclosure - USD ($)
1 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended
Jan. 18, 2023
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure                
Net Income (Loss) $ (6,646) $ 738,891 $ 575,856 $ 1,435,806 $ 1,143,965 $ 2,586,417 $ 1,314,747 $ 2,579,771
v3.24.2.u1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.2.u1
Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2024
Significant Accounting Policies  
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, the financial statements do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2023 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The interim results for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future interim periods.

Emerging Growth Company

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies.

The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

Use of Estimates

The preparation of financial statement in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of June 30, 2024 and December 31, 2023, the Company had $66,926 and $671,628 in cash and cash equivalents, respectively.

Cash and Marketable Securities held in Trust Account

Cash and Marketable Securities held in Trust Account

Following the closing of the Initial Public Offering on January 18, 2023, an amount of $146,625,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units were placed in the Trust Account and may be invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Trust Account is intended as a holding place for funds pending the earliest to occur of: (i) the completion of the initial Business Combination; (ii) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination within 12 months from the closing of the Initial Public Offering or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within 12 months from the closing of the Initial Public Offering, the return of the funds held in the Trust Account to the public shareholders as part of redemption of the public shares.

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2024 and December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Class A Ordinary Shares Subject to Possible Redemption

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2024, 7,259,615 Class A ordinary shares subject to possible redemption are presented as temporary equity, at redemption value, as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit.

The Class A ordinary shares subject to possible redemption is reflected on the balance sheet at June 30, 2024 as follows:

Gross proceeds from Initial Public Offering

    

$

143,750,000

Less:

 

Proceeds allocated to public warrants

 

(354,359)

Offering costs allocated to Class A ordinary shares subject to possible redemption

 

(8,642,235)

Plus:

 

Accretion of Class A ordinary shares subject to possible redemption

 

18,948,600

Class A ordinary shares subject to possible redemption at December 31, 2023

153,702,006

Redemption of Class A ordinary shares

(75,921,158)

Re-measurement of Class A ordinary shares subject to possible redemption

2,532,923

Class A ordinary shares subject to possible redemption at June 30, 2024

$

80,313,771

Offering Costs associated with the Initial Public Offering

Offering Costs associated with the Initial Public Offering

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of Offering”. Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. The Company incurred offering costs from the Initial Public Offering of $8,642,235, consisting of $2,500,000 of underwriting fee, $5,406,250 of deferred underwriting fee, $735,985 of actual offering costs. These amounts were recorded to additional paid-in capital as a reduction to the net proceeds from the offering.

Fair Value Measurements

Fair Value Measurements

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurements and Disclosures” (“ASC 820”), defines fair value as the amount that would be received to sell an asset or paid to transfer a liability, in an orderly transaction between market participants. Fair value measurements are classified on a three-tier hierarchy as follows:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. ln those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

The fair value of the Company’s assets and liabilities that qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Financial Instruments

Financial Instruments

The fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Derivative Financial Instruments

Derivative Financial Instruments

The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period. There were no derivative financial instruments accounted for as liabilities as of June 30, 2024 and December 31, 2023.

Warrants

Warrants

The Company accounts for the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in FASB ASC Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). Pursuant to the Company’s evaluation, the Company concluded that the public and private do not meet the criteria to be accounted for as liability under ASC 480. The Company further evaluated the public and private warrants and rights under “ASC 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity” (“ASC 815-40”) and concluded that the public warrants, private placement warrants are indexed to the Company’s own stock and meet the criteria to be classified in shareholders’ equity.

Income Taxes

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” (“ASC 740”) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2024 and December 31, 2023. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company is not currently aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to tax examinations by major taxing authorities since inception. There is currently no taxation imposed by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

There is currently no taxation imposed by the government of the Cayman Islands. The Company has no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. Consequently, income taxes are not reflected in the Company’s financial statement.

Net Income (Loss) Per Ordinary Share

Net Income (Loss) Per Ordinary Share

The statement of operations includes a presentation of income (loss) per Class A redeemable ordinary share and income (loss) per non-redeemable ordinary share following the two-class method of income per ordinary share. In order to determine the net income (loss) attributable to both the Class A redeemable ordinary shares and non-redeemable ordinary shares, the Company first considered the total net income (loss) allocable to both sets of shares. This is calculated using the total net income (loss) less any dividends paid. For purposes of calculating net income (loss) per share, any remeasurement of the Class A ordinary shares subject to possible redemption was treated as dividends paid to the public shareholders.

Net income (loss) per ordinary share is computed by dividing net income (loss) by class by the weighted average number of ordinary shares outstanding during the period. The Company has not considered the effect of the 14,375,000 Public Warrants in the calculation of diluted net income (loss) per share, since the exercise of such warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the three months ended June 30, 2024 (in dollars, except share amounts):

    

Three Months Ended

June 30, 2024

Net income

$

738,891

Accretion of temporary equity to redemption value

 

(1,181,091)

Net loss including accretion of temporary equity to redemption value

$

(442,200)

Three Months Ended

June 30, 2024

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

418,616

$

43,969

$

276,306

Less: Accretion allocation based on ownership percentage

$

(669,144)

$

(70,282)

(441,665)

Allocation of accretion of temporary equity to redeemable shares

1,181,091

Total net income (loss) by class

$

930,563

$

(26,313)

(165,359)

Denominator:

Weighted average shares outstanding

7,259,615

762,500

4,791,667

Basic and diluted net income (loss) per share

$

0.13

$

(0.03)

(0.03)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the six months ended June 30, 2024 (in dollars, except share amounts):

    

Six Months Ended

June, 2024

Net income

$

1,314,747

Accretion of temporary equity to redemption value

 

(2,532,923)

Net loss including accretion of temporary equity to redemption value

$

(1,218,176)

Six Months Ended

June 30, 2024

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

744,866

$

78,236

$

491,645

Less: Accretion allocation based on ownership percentage

$

(1,435,021)

$

(150,725)

 

(947,177)

Allocation of accretion of temporary equity to redeemable shares

 

2,532,923

 

 

Total net income (loss) by class

$

1,842,768

$

(72,489)

 

(455,532)

Denominator:

 

  

 

  

 

  

Weighted average shares outstanding

 

7,572,379

 

762,500

 

4,791,667

Basic and diluted net income (loss) per share

$

0.24

$

(0.10)

 

(0.10)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the three months ended June 30, 2023 (in dollars, except share amounts):

    

Three Months Ended

June 30, 2023

Net income

$

1,435,806

Accretion of temporary equity to redemption value

 

(1,743,579)

Net loss including accretion of temporary equity to redemption value

$

(307,773)

Three Months Ended

June 30, 2023

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

1,035,653

$

54,935

$

345,218

Less: Accretion allocation based on ownership percentage

$

(1,257,652)

$

(66,710)

 

(419,217)

Allocation of accretion of temporary equity to redeemable shares

 

1,743,579

 

 

Total net income (loss) by class

$

1,521,580

$

(11,775)

 

(73,999)

Denominator:

 

  

 

  

 

  

Weighted average shares outstanding

 

1,437,000

 

762,500

 

4,791,667

Basic and diluted net income per share

$

0.11

$

(0.02)

 

(0.02)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the six months ended June 30, 2023 (in dollars, except share amounts):

    

Six Months Ended

June 30, 2023

Net loss from beginning on the year to date of initial public offering

$

(6,646)

Net income from date of initial public offering to period end

 

2,586,417

Total income for the three months ended June 30, 2023

 

2,579,771

Accretion of temporary equity to redemption value

 

(14,974,488)

Net loss including accretion of temporary equity to redemption value

$

(12,394,717)

    

Six Months Ended

June 30, 2023

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

  

 

  

Numerator:

 

  

  

 

  

Allocation of net loss from inception to date of initial public offering

$

$

$

(6,646)

Allocation of net income from date of initial public offering to period end

1,865,594

98,958

621,865

Total income allocated by class

1,865,594

98,958

615,219

Less: Accretion allocation based on ownership percentage

$

(10,801,168)

$

(572,931)

(3,600,389)

Allocation of accretion of temporary equity to redeemable shares

14,974,488

Total net income (loss) by class

$

6,038,914

$

(473,973)

(2,985,170)

Denominator:

Weighted average shares outstanding

13,024,862

690,884

4,791,667

Basic and diluted net income per share

$

0.46

$

(0.69)

(0.62)

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In December 2023, the FASB issued Accounting Standards Update 2023-09, “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which provides for additional disclosures primarily related to the income tax rate reconciliations and income taxes paid. ASU 2023-09 requires entities to annually disclose the income tax rate reconciliation using both amounts and percentages, considering several categories of reconciling items, including state and local income taxes, foreign tax effects, tax credits and nontaxable or nondeductible items, among others. Disclosure of the reconciling items is subject to a quantitative threshold and disaggregation by nature and jurisdiction. ASU 2023-09 also requires entities to disclose net income taxes paid or received to federal, state and foreign jurisdictions, as well as by individual jurisdiction, subject to a five percent quantitative threshold. ASU 2023-09 may be adopted on a prospective or retrospective basis and is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2023-09 would have on its financial position, results of operations or cash flows.

The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying financial statements.

v3.24.2.u1
Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2024
Significant Accounting Policies  
Schedule of condensed balance sheet are reconciled

The Class A ordinary shares subject to possible redemption is reflected on the balance sheet at June 30, 2024 as follows:

Gross proceeds from Initial Public Offering

    

$

143,750,000

Less:

 

Proceeds allocated to public warrants

 

(354,359)

Offering costs allocated to Class A ordinary shares subject to possible redemption

 

(8,642,235)

Plus:

 

Accretion of Class A ordinary shares subject to possible redemption

 

18,948,600

Class A ordinary shares subject to possible redemption at December 31, 2023

153,702,006

Redemption of Class A ordinary shares

(75,921,158)

Re-measurement of Class A ordinary shares subject to possible redemption

2,532,923

Class A ordinary shares subject to possible redemption at June 30, 2024

$

80,313,771

Schedule of Reconciliation of net loss per common share

    

Three Months Ended

June 30, 2024

Net income

$

738,891

Accretion of temporary equity to redemption value

 

(1,181,091)

Net loss including accretion of temporary equity to redemption value

$

(442,200)

Three Months Ended

June 30, 2024

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

418,616

$

43,969

$

276,306

Less: Accretion allocation based on ownership percentage

$

(669,144)

$

(70,282)

(441,665)

Allocation of accretion of temporary equity to redeemable shares

1,181,091

Total net income (loss) by class

$

930,563

$

(26,313)

(165,359)

Denominator:

Weighted average shares outstanding

7,259,615

762,500

4,791,667

Basic and diluted net income (loss) per share

$

0.13

$

(0.03)

(0.03)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the six months ended June 30, 2024 (in dollars, except share amounts):

    

Six Months Ended

June, 2024

Net income

$

1,314,747

Accretion of temporary equity to redemption value

 

(2,532,923)

Net loss including accretion of temporary equity to redemption value

$

(1,218,176)

Six Months Ended

June 30, 2024

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

744,866

$

78,236

$

491,645

Less: Accretion allocation based on ownership percentage

$

(1,435,021)

$

(150,725)

 

(947,177)

Allocation of accretion of temporary equity to redeemable shares

 

2,532,923

 

 

Total net income (loss) by class

$

1,842,768

$

(72,489)

 

(455,532)

Denominator:

 

  

 

  

 

  

Weighted average shares outstanding

 

7,572,379

 

762,500

 

4,791,667

Basic and diluted net income (loss) per share

$

0.24

$

(0.10)

 

(0.10)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the three months ended June 30, 2023 (in dollars, except share amounts):

    

Three Months Ended

June 30, 2023

Net income

$

1,435,806

Accretion of temporary equity to redemption value

 

(1,743,579)

Net loss including accretion of temporary equity to redemption value

$

(307,773)

Three Months Ended

June 30, 2023

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income by class

$

1,035,653

$

54,935

$

345,218

Less: Accretion allocation based on ownership percentage

$

(1,257,652)

$

(66,710)

 

(419,217)

Allocation of accretion of temporary equity to redeemable shares

 

1,743,579

 

 

Total net income (loss) by class

$

1,521,580

$

(11,775)

 

(73,999)

Denominator:

 

  

 

  

 

  

Weighted average shares outstanding

 

1,437,000

 

762,500

 

4,791,667

Basic and diluted net income per share

$

0.11

$

(0.02)

 

(0.02)

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share for the six months ended June 30, 2023 (in dollars, except share amounts):

    

Six Months Ended

June 30, 2023

Net loss from beginning on the year to date of initial public offering

$

(6,646)

Net income from date of initial public offering to period end

 

2,586,417

Total income for the three months ended June 30, 2023

 

2,579,771

Accretion of temporary equity to redemption value

 

(14,974,488)

Net loss including accretion of temporary equity to redemption value

$

(12,394,717)

    

Six Months Ended

June 30, 2023

Class B Non-

    

Class A Redeemable

    

Class A Non-redeemable

    

redeemable

Basic and diluted net income (loss) per share:

 

  

  

 

  

Numerator:

 

  

  

 

  

Allocation of net loss from inception to date of initial public offering

$

$

$

(6,646)

Allocation of net income from date of initial public offering to period end

1,865,594

98,958

621,865

Total income allocated by class

1,865,594

98,958

615,219

Less: Accretion allocation based on ownership percentage

$

(10,801,168)

$

(572,931)

(3,600,389)

Allocation of accretion of temporary equity to redeemable shares

14,974,488

Total net income (loss) by class

$

6,038,914

$

(473,973)

(2,985,170)

Denominator:

Weighted average shares outstanding

13,024,862

690,884

4,791,667

Basic and diluted net income per share

$

0.46

$

(0.69)

(0.62)

v3.24.2.u1
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2024
Fair Value Measurements  
Schedule of assets and liabilities that were accounted for at fair value on a recurring basis

June 30,2024

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets

 

  

 

  

 

  

Cash equivalents(1)

$

66,926

$

$

Cash and marketable securities held in Trust Account(2)

$

80,313,771

$

$

    

December 31, 2023

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets

  

 

  

 

  

Cash equivalents(1)

$

671,628

$

$

Cash and marketable securities held in Trust Account(2)

$

153,702,006

$

$

(1)The fair value of money market funds have been measured on a recurring basis using Level 1 inputs, which are based on unadjusted quoted market prices within active markets.
(2)The fair value of the marketable securities held in the Trust Account approximates the carrying amount primarily due to their short-term nature.
v3.24.2.u1
Description of Organization, Business Operations and Liquidity and Capital Resources (Details)
6 Months Ended
Jan. 08, 2024
USD ($)
item
$ / shares
Jan. 18, 2023
USD ($)
$ / shares
shares
Aug. 24, 2021
item
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
$ / shares
Jan. 08, 2023
$ / shares
Description of Organization and Business Operations              
Condition for future business combination number of businesses minimum | item     1        
Maximum number of extensions | item 12            
Extension period 1 month            
Notice period for extension 5 days            
Deposits | $ $ 50,000            
Deposits, price per public share $ 0.02            
Operating cash | $       $ 66,926   $ 671,628  
Working capital deficit | $       $ 663,702      
Working capital | $           $ 554,474  
Payments of stock issuance cost | $         $ 487,401    
Common Class B              
Description of Organization and Business Operations              
Ordinary shares, Par value (in dollars per share)       $ 0.0001   $ 0.0001  
Common Class B | Sponsor              
Description of Organization and Business Operations              
Aggregate proceeds held in the Trust Account | $       $ 25,000      
Common Class A              
Description of Organization and Business Operations              
Ordinary shares, Par value (in dollars per share)       $ 0.0001   $ 0.0001  
Common Class A | Private shares              
Description of Organization and Business Operations              
Ordinary shares, Par value (in dollars per share)   $ 0.001          
Common Class A | Warrant [Member]              
Description of Organization and Business Operations              
Purchase price   11.50          
Common Class A | Public Warrants              
Description of Organization and Business Operations              
Purchase price   $ 11.50          
Initial Public Offering              
Description of Organization and Business Operations              
Sale of units (in shares) | shares   14,375,000          
Ordinary shares, par value (per share)   $ 10.00         $ 10.20
Gross proceeds | $   $ 143,750,000          
Condition for future business combination use of proceeds percentage   80.00%          
Condition for future business combination threshold Percentage Ownership   50.00%          
Minimum net tangible assets upon consummation of business combination | $   $ 5,000,001          
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)   100.00%          
Initial Public Offering | Public Shares              
Description of Organization and Business Operations              
Sale of units (in shares) | shares   1,875,000          
Ordinary shares, par value (per share)   $ 10.20          
Net Proceeds | $   $ 146,625,000          
Business combination consummation period 12 months            
Initial Public Offering | Private Placement Warrants              
Description of Organization and Business Operations              
Sale of units (in shares) | shares   762,500          
Number of warrants in a unit | shares   1          
Ordinary shares, par value (per share)   $ 10.00          
Purchase price   $ 11.50          
Proceeds from sale of Private Placement Warrants | $   $ 7,625,000          
Initial Public Offering | Public Warrants              
Description of Organization and Business Operations              
Number of shares in a unit | shares   1          
Number of warrants in a unit | shares   1          
Initial Public Offering | Common Class A | Private shares              
Description of Organization and Business Operations              
Number of shares in a unit | shares   1          
Ordinary shares, Par value (in dollars per share)   $ 0.0001          
Initial Public Offering | Common Class A | Public Shares              
Description of Organization and Business Operations              
Ordinary shares, Par value (in dollars per share)   $ 0.001          
Private Placement              
Description of Organization and Business Operations              
Sale of units (in shares) | shares       762,500      
Number of shares in a unit | shares       1      
Number of warrants in a unit | shares       1      
Ordinary shares, par value (per share)       $ 10.00      
Private Placement | Common Class A              
Description of Organization and Business Operations              
Purchase price       $ 11.50      
Over-allotment option              
Description of Organization and Business Operations              
Sale of units (in shares) | shares       1,875,000      
v3.24.2.u1
Significant Accounting Policies (Details) - USD ($)
6 Months Ended
Jan. 18, 2023
Jun. 30, 2024
Dec. 31, 2023
Significant Accounting Policies      
Cash and cash equivalents   $ 66,926 $ 671,628
Offering costs   8,642,235  
Underwriting fee   2,500,000  
Deferred underwriting fee   5,406,250 5,406,250
Actual offering costs   $ 735,985  
Shares excluded from calculation of diluted loss per share   14,375,000  
Unrecognized tax benefits   $ 0 $ 0
Class A ordinary shares subject to possible redemption      
Significant Accounting Policies      
Temporary equity, shares outstanding   7,259,615  
Money market funds      
Significant Accounting Policies      
Net proceeds from sale of units $ 146,625,000    
Percentage redemption of public share 100.00%    
v3.24.2.u1
Significant Accounting Policies - Schedule of condensed balance sheet (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Significant Accounting Policies              
Accretion of Class A ordinary shares subject to possible redemption $ 1,181,091   $ 1,743,579   $ 2,532,923 $ 14,974,488  
Net loss including accretion of temporary equity to redemption value (1,181,091) $ (1,351,832) (1,743,579) $ (13,230,909)      
Class A ordinary shares not subject to possible redemption              
Significant Accounting Policies              
Net loss including accretion of temporary equity to redemption value           (12,394,717)  
Class A ordinary shares subject to possible redemption              
Significant Accounting Policies              
Gross proceeds from initial public offering             $ 143,750,000
Proceeds allocated to public warrants             (354,359)
Offering costs allocated to Class A ordinary shares subject to possible redemption             (8,642,235)
Accretion of Class A ordinary shares subject to possible redemption $ 1,181,091   $ 1,743,579   2,532,923 $ 14,974,488 $ 18,948,600
Net loss including accretion of temporary equity to redemption value         (2,532,923)    
Redemption of Class A ordinary shares         $ (75,921,158)    
v3.24.2.u1
Significant Accounting Policies - Basic and diluted net income (loss) per ordinary share (Details) - USD ($)
1 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended 12 Months Ended
Jan. 18, 2023
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Significant Accounting Policies                  
Net income $ (6,646) $ 738,891 $ 575,856 $ 1,435,806 $ 1,143,965 $ 2,586,417 $ 1,314,747 $ 2,579,771  
Accretion of Class A ordinary shares subject to possible redemption   (1,181,091)   (1,743,579)     (2,532,923) (14,974,488)  
Net loss including accretion of temporary equity to redemption value   (442,200)   (307,773)     (1,218,176)    
Numerator:                  
Allocation of net income by class   (442,200)   (307,773)     (1,218,176)    
Allocation of accretion of temporary equity to redeemable shares   1,181,091   1,743,579     2,532,923 14,974,488  
Class A Redeemable                  
Significant Accounting Policies                  
Accretion of Class A ordinary shares subject to possible redemption   (1,181,091)   (1,743,579)     (2,532,923) (14,974,488) $ (18,948,600)
Net loss including accretion of temporary equity to redemption value   418,616   1,035,653   1,865,594 744,866 1,865,594  
Numerator:                  
Allocation of net income by class   418,616   1,035,653   1,865,594 744,866 1,865,594  
Less: Accretion allocation based on ownership percentage   (669,144)   (1,257,652)     (1,435,021) (10,801,168)  
Allocation of accretion of temporary equity to redeemable shares   1,181,091   1,743,579     2,532,923 14,974,488 $ 18,948,600
Total net income (loss) by class   $ 930,563   $ 1,521,580     $ 1,842,768 $ 6,038,914  
Denominator:                  
Weighted average shares outstanding, Basic   7,259,615   1,437,000     7,572,379 13,024,862  
Weighted average shares outstanding, Diluted   7,259,615   1,437,000     7,572,379 13,024,862  
Basic net income (loss) per share (in dollars per share)   $ 0.13   $ 0.11     $ 0.24 $ 0.46  
Diluted net income (loss) per share (in dollars per share)   $ 0.13   $ 0.11     $ 0.24 $ 0.46  
Class A Non-redeemable                  
Significant Accounting Policies                  
Net loss including accretion of temporary equity to redemption value   $ 43,969   $ 54,935   98,958 $ 78,236 $ 98,958  
Numerator:                  
Allocation of net income by class   43,969   54,935   98,958 78,236 98,958  
Less: Accretion allocation based on ownership percentage   (70,282)   (66,710)     (150,725) (572,931)  
Total net income (loss) by class   $ (26,313)   $ (11,775)     $ (72,489) $ (473,973)  
Denominator:                  
Weighted average shares outstanding, Basic   762,500   762,500     762,500 690,884  
Weighted average shares outstanding, Diluted   762,500   762,500     762,500 690,884  
Basic net income (loss) per share (in dollars per share)   $ (0.03)   $ (0.02)     $ (0.10) $ (0.69)  
Diluted net income (loss) per share (in dollars per share)   $ (0.03)   $ (0.02)     $ (0.10) $ (0.69)  
Class A ordinary shares not subject to possible redemption                  
Denominator:                  
Weighted average shares outstanding, Basic   762,500   762,500     762,500 690,884  
Weighted average shares outstanding, Diluted   762,500   762,500     762,500 690,884  
Basic net income (loss) per share (in dollars per share)   $ (0.03)   $ (0.02)     $ (0.10) $ (0.69)  
Diluted net income (loss) per share (in dollars per share)   $ (0.03)   $ (0.02)     $ (0.10) $ (0.69)  
Class B Non-redeemable                  
Significant Accounting Policies                  
Net loss including accretion of temporary equity to redemption value (6,646) $ 276,306   $ 345,218   621,865 $ 491,645 $ 615,219  
Numerator:                  
Allocation of net income by class $ (6,646) 276,306   345,218   $ 621,865 491,645 615,219  
Less: Accretion allocation based on ownership percentage   (441,665)   (419,217)     (947,177) (3,600,389)  
Total net income (loss) by class   $ (165,359)   $ (73,999)     $ (455,532) $ (2,985,170)  
Denominator:                  
Weighted average shares outstanding, Basic   4,791,667   4,791,667     4,791,667    
Weighted average shares outstanding, Diluted   4,791,667   4,791,667     4,791,667 4,791,667  
Basic net income (loss) per share (in dollars per share)   $ (0.03)   $ (0.02)     $ (0.10) $ (0.62)  
Diluted net income (loss) per share (in dollars per share)   $ (0.03)   $ (0.02)     $ (0.10) $ (0.62)  
v3.24.2.u1
Initial Public Offering (Details) - USD ($)
Jan. 18, 2023
Jun. 30, 2024
Dec. 31, 2023
Jan. 08, 2023
Initial Public Offering        
Cash and marketable securities held in trust account   $ 80,313,771 $ 153,702,006  
Operating cash   $ 66,926 $ 671,628  
Class A ordinary shares | Public Warrants        
Initial Public Offering        
Purchase price $ 11.50      
Initial Public Offering        
Initial Public Offering        
Number of units sold 14,375,000      
Offering price per share $ 10.00     $ 10.20
Share Price $ 10.20      
Initial Public Offering | Public Warrants        
Initial Public Offering        
Number of shares in a unit 1      
Number of warrants in a unit 1      
Number of shares issuable per warrant 1      
v3.24.2.u1
Related Party Transactions - Founder Shares (Details) - USD ($)
May 07, 2023
Nov. 17, 2022
Aug. 18, 2022
Mar. 04, 2022
Jan. 26, 2022
Jun. 30, 2024
Dec. 31, 2023
Common Class B              
Related Party Transactions              
Common stock, shares outstanding   4,791,667 5,750,000     4,791,667 4,791,667
Common Class B | Sponsor              
Related Party Transactions              
Consideration for shares surrender   0 0        
Founder Shares | Sponsor              
Related Party Transactions              
Number of shares transferred (in shares) 95,500 958,333 1,150,000 6,900,000      
Number of shares surrender   958,333 1,150,000        
Common stock, shares outstanding   4,791,667 5,750,000 6,900,000      
Founder Shares | Common Class B              
Related Party Transactions              
Number of shares transferred (in shares)       1,150,000      
Founder Shares | Common Class B | Sponsor              
Related Party Transactions              
Number of shares issued         5,750,000    
Ordinary shares, par value (per share)         $ 0.0001    
Aggregate purchase price         $ 25,000    
v3.24.2.u1
Related Party Transactions - Private Placement (Details) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Related Party Transactions    
Aggregate purchase price   $ 7,625,000
Private Placement    
Related Party Transactions    
Number of units sold 762,500  
Offering price per share $ 10.00  
Aggregate purchase price   $ 7,625,000
Number of shares in a unit 1  
Number of warrants in a unit 1  
Number of shares issuable per warrant 1  
Private Placement | Common Class A    
Related Party Transactions    
Exercise price of warrants (in dollars per share) $ 11.50  
v3.24.2.u1
Related Party Transactions - Related Party Loans (Details) - Working Capital Loans - Related Party Loans - USD ($)
6 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Related Party Transactions    
Proceeds held in trust account used to repay working capital loan $ 0  
Maximum amount of loan convertible $ 1,500,000  
Offering price per share $ 10.00  
Outstanding balance $ 0 $ 0
v3.24.2.u1
Related Party Transactions - Promissory Note from Related Party (Details) - Promissory note
Jun. 14, 2024
USD ($)
May 17, 2024
USD ($)
Apr. 15, 2024
USD ($)
Mar. 11, 2024
USD ($)
Feb. 15, 2024
USD ($)
Jan. 18, 2024
USD ($)
M
Jan. 16, 2024
USD ($)
Jan. 18, 2023
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Jan. 26, 2022
USD ($)
Related Party Transactions                      
Aggregate principal amount                     $ 300,000
Amount borrowed               $ 237,234      
Annual payments               245,540      
Related Party                      
Related Party Transactions                      
Overpayment of related party receivable               $ 8,306      
Outstanding balance                 $ 0 $ 0  
Sponsor                      
Related Party Transactions                      
Aggregate principal amount           $ 600,000          
Outstanding balance                 $ 300,000 $ 0  
Number of extension payments | M           12          
Extension payments period           1 month          
Promissory notes to pay each month extension expenses $ 50,000 $ 50,000 $ 50,000 $ 50,000 $ 50,000   $ 50,000        
Promissory notes to pay extension expenses $ 300,000 $ 300,000 $ 300,000 $ 300,000 $ 300,000   $ 300,000        
v3.24.2.u1
Related Party Transactions - Administrative Services Agreement (Details) - Administrative Services Agreement - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Related Party Transactions          
Expenses per month paid     $ 10,000    
Accrued expenses related party     60,000   $ 116,129
Administrative expense $ 30,000 $ 30,000 $ 60,000 $ 56,129  
v3.24.2.u1
Commitments & Contingencies (Details)
6 Months Ended
Jan. 18, 2023
shares
Jun. 30, 2024
USD ($)
item
shares
Commitments & Contingencies    
Maximum number of demands for registration of securities | item   2
Initial Public Offering    
Commitments & Contingencies    
Number of units sold | shares 14,375,000  
Payment of underwriting fee | $   $ 2,500,000
Underwriting fee (in percentage)   3.50
Over-allotment option    
Commitments & Contingencies    
Granted Term   45 days
Number of units sold | shares   1,875,000
Underwriting fee (in percentage)   5.50
Deferred underwriting commission | $   $ 5,406,250
v3.24.2.u1
Shareholders' Equity (Deficit) - Preference shares (Details) - $ / shares
Jun. 30, 2024
Dec. 31, 2023
Shareholders' Equity (Deficit)    
Preferred shares, shares authorized 2,000,000 2,000,000
Preference shares, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred shares, shares issued 0 0
Preferred shares, shares outstanding 0 0
v3.24.2.u1
Shareholders' Equity (Deficit) - Ordinary shares (Details)
6 Months Ended
Jan. 08, 2024
shares
May 07, 2023
shares
Nov. 17, 2022
shares
Aug. 18, 2022
shares
Mar. 04, 2022
USD ($)
shares
Jun. 30, 2024
Vote
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Shareholders' Equity (Deficit)              
Threshold conversion ratio of stock           1  
Sponsor | Founder Shares              
Shareholders' Equity (Deficit)              
Ordinary shares, share outstanding     4,791,667 5,750,000 6,900,000    
Number of shares transferred (in shares)   95,500 958,333 1,150,000 6,900,000    
Class A ordinary shares              
Shareholders' Equity (Deficit)              
Ordinary shares, shares authorized (in shares)           200,000,000 200,000,000
Ordinary shares, par value (in dollars per share) | $ / shares           $ 0.0001 $ 0.0001
Class A ordinary shares subject to possible redemption              
Shareholders' Equity (Deficit)              
Temporary equity, shares issued           7,259,615 14,375,000
Temporary equity, shares outstanding           7,259,615 14,375,000
Class A ordinary shares not subject to possible redemption              
Shareholders' Equity (Deficit)              
Ordinary shares, shares issued (in shares)           762,500 762,500
Ordinary shares, share outstanding           762,500 762,500
Class A ordinary shares subject to possible redemption              
Shareholders' Equity (Deficit)              
Temporary equity, shares issued           7,259,615 14,375,000
Temporary equity, shares outstanding           7,259,615 14,375,000
Redemption of Class A ordinary shares (in shares) 7,115,385            
Class B ordinary shares              
Shareholders' Equity (Deficit)              
Ordinary shares, shares authorized (in shares)           20,000,000 20,000,000
Ordinary shares, par value (in dollars per share) | $ / shares           $ 0.0001 $ 0.0001
Ordinary shares, shares issued (in shares)           4,791,667 4,791,667
Ordinary shares, share outstanding     4,791,667 5,750,000   4,791,667 4,791,667
Ordinary shares, votes per share | Vote           1  
Ratio to be applied to the stock in the conversion           25  
Class B ordinary shares | Founder Shares              
Shareholders' Equity (Deficit)              
Number of shares transferred (in shares)         1,150,000    
Class B ordinary shares | Sponsor              
Shareholders' Equity (Deficit)              
Consideration for shares surrender     0 0      
Class B ordinary shares | Sponsor | Founder Shares              
Shareholders' Equity (Deficit)              
Share capitalization | $         $ 1,150,000    
v3.24.2.u1
Shareholders' Equity (Deficit) - Warrants (Details)
6 Months Ended
Jun. 30, 2024
D
$ / shares
Shareholders' Equity (Deficit)  
Maximum threshold period for registration statement to become effective after business combination 60 days
Percentage of aggregate voting power for holder of a warrant entitled to receive the highest amount of cash 50.00%
Maximum consideration receivable to decrease warrant price 70.00%
Warrant exercise term from public disclosure of the consummation of the applicable event to decrease warrant price 30 days
Maximum  
Shareholders' Equity (Deficit)  
Maximum threshold period for registration statement to become effective after business combination 61 days
Warrants  
Shareholders' Equity (Deficit)  
Maximum period after business combination in which to file registration statement 15 days
Warrants | Class A ordinary shares  
Shareholders' Equity (Deficit)  
Redemption price per public warrant (in dollars per share) $ 11.50
Warrant exercise period condition one 30 days
Public Warrants expiration term 5 years
Private Placement Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00  
Shareholders' Equity (Deficit)  
Redemption price per public warrant (in dollars per share) $ 18.00
Public Warrants  
Shareholders' Equity (Deficit)  
Share price trigger used to measure dilution of warrant $ 9.20
Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant 60
Trading period after business combination used to measure dilution of warrant | D 20
Warrant exercise price adjustment multiple 115
Warrant redemption price adjustment multiple 180
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00  
Shareholders' Equity (Deficit)  
Redemption price per public warrant (in dollars per share) $ 0.01
Stock price trigger for redemption of public warrants (in dollars per share) $ 18.00
Redemption period 30 days
Warrant redemption condition minimum share price $ 18.00
v3.24.2.u1
Fair Value Measurements (Details) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Fair Value Measurements    
Cash and marketable securities held in Trust Account $ 80,313,771 $ 153,702,006
Level 1 | Recurring    
Fair Value Measurements    
Cash equivalents 66,926 671,628
Cash and marketable securities held in Trust Account $ 80,313,771 $ 153,702,006
v3.24.2.u1
Subsequent Events (Details) - Subsequent event - USD ($)
Aug. 14, 2024
Jul. 17, 2024
Subsequent Events    
Additional amount utilized against extension note   $ 50,000
July Promissory note    
Subsequent Events    
Aggregate principal amount   $ 1,500,000
Outstanding balance $ 150,000  

Israel Acquisitions (NASDAQ:ISRLU)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Israel Acquisitions Charts.
Israel Acquisitions (NASDAQ:ISRLU)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Israel Acquisitions Charts.